ILD, hospital admissions

ILD_HOSPITAL

interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J84 Hospital discharge: ICD-9 — 515\|516 Hospital discharge: ICD-8 — 48499\|51701 1 out of 7 registries used, show all original rules.	7464
4. Check minimum number of events None	7464
5. Include endpoints None	7464
6. Filter based on genotype QC (FinnGen only)	6589

Control definitions (FinnGen only)

Control exclude: ILD_HOSPITAL_PULM_INFECT

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J80-J84
Name in latin: Alii morbi interstitiales pulmonum

NAME	ILD_HOSPITAL
CONTROL_EXCLUDE	ILD_HOSPITAL_PULM_INFECT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J84
HD_ICD_9	515\|516
HD_ICD_8	48499\|51701
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to ILD, hospital admissions based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6589	2651	3938
Unadjusted period prevalence (%)	1.46	0.94	1.81
Median age at first event (years)	70.14	67.98	71.59

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6770: Matched controls
67700

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.9

315.8

1059

3072

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.6

313.2

821

1983

UGC12

NOMESCO Finland

Flexible bronchoscopy

10.1

307.7

2334

3364

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4494.1

307.7

3686

R06.0

ICD-10 Finland

Dyspnoea

3.2

307.7

3087

14226

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.5

307.7

891

2212

TGC00

NOMESCO Finland

Bronchial lavation

30.7

307.7

1544

646

356

Kela drug reimbursment

Nintedanib and pirfenidone

3426.9

307.7

644

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

9.4

307.7

710

832

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

7.6

307.7

2542

4956

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.0

307.7

3639

15302

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

6.1

307.7

1021

1928

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

29.9

307.7

284

R03AC02

ATC

salbutamol; inhalant

2.7

307.7

4290

26478

L04AX05

ATC

pirfenidone; oral

+∞

307.7

420

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

24.8

307.7

2563

1621

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.9

307.7

4988

28436

GD1AD

NOMESCO Finland

Thorax CT examination

6.9

307.7

1454

2588

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

15.8

307.7

1069

792

L04AA06

ATC

mycophenolic acid; systemic

14.0

307.7

526

404

J96.1

ICD-10 Finland

Chronic respiratory failure

8.3

307.7

582

761

284

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

307.7

646

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

9003.4

307.7

1974

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

23.1

307.7

358

163

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.7

307.7

1572

4082

H02AB06

ATC

prednisolone; systemic

5.2

307.7

5128

25274

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

70.7

307.7

252

L04AX01

ATC

azathioprine; systemic

7.5

307.7

743

1101

L01EX09

ATC

nintedanib; oral

1845.7

307.7

336

XG410

NOMESCO Finland

Flow-volume spirometry

8.0

307.7

908

1282

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

1481.5

307.7

3161

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.5

301.0

3259

18094

P01BA02

ATC

hydroxychloroquine; oral

3.9

286.0

942

2689

Z94.2

ICD-10 Finland

Lung transplant status

77.7

284.3

152

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.2

268.0

1228

4331

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

4.4

260.8

713

1771

J01MA14

ATC

moxifloxacin; systemic

3.3

248.3

1078

3669

GX1K5

NOMESCO Finland

Diffusion capacity

17.6

247.5

203

119

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.1

244.1

744

2001

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

6.0

235.2

434

768

GX1D5

NOMESCO Finland

Flow volume spirometry

33.4

225.5

144

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

20.7

218.8

166

L01XE31

ATC

[U] nintedanib

+∞

216.8

207

R03BB04

ATC

tiotropium bromide; inhalant

2.8

204.3

1242

5071

J84.0

ICD-10 Finland

Alveolar and parietoalveolar conditions

1883.7

199.8

193

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

192.4

1835

9242

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.3

190.1

518

1276

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

10.2

172.5

196

198

A02BC02

ATC

pantoprazole; systemic

2.2

172.3

5113

39248

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

9.4

168.2

202

220

M05BA04

ATC

alendronic acid; oral

2.8

167.8

963

3789

C03CA01

ATC

furosemide; systemic

2.0

165.9

3135

20318

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

7.4

165.5

245

344

48499

ICD-8 Finland

Acute interstitial pneumonia

+∞

164.2

157

L04AX03

ATC

methotrexate; systemic

2.9

163.0

875

3319

R05

ICD-10 Finland

Cough

2.2

156.3

1787

9580

J47

ICD-10 Finland

Bronchiectasis

5.5

155.8

311

590

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.2

152.4

656

2192

L04AA13

ATC

[U] leflunomide

5.4

151.5

308

594

WX721

NOMESCO Finland

Oxygen concentrator therapy

21.9

146.1

108

R02

ICPC

Shortness of breath/dyspnoea

2.3

143.5

1313

6401

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

10.6

143.0

157

151

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

142.9

1589

8385

R03AK08

ATC

formoterol and beclometasone; inhalant

3.6

136.8

468

1350

A07EC01

ATC

sulfasalazine; oral, rectal

2.9

135.9

718

2689

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

344.0

135.1

136

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.2

134.5

370

914

GDG10

NOMESCO Finland

Bilateral transplantation of lung

202.7

134.2

139

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

8.6

133.0

171

203

J43.9

ICD-10 Finland

Emphysema, unspecified

5.2

132.8

277

546

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

+∞

129.6

124

L01BA01

ATC

methotrexate; systemic

3.9

129.6

399

1070

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

129.4

1173

5673

J01MA12

ATC

levofloxacin; systemic

2.0

127.0

1685

9446

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.7

126.3

239

431

XX4BW, ,

NOMESCO Finland

37.1

124.1

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

4.8

122.4

283

609

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

122.3

2134

13118

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.6

122.2

420

1214

R03BA08

ATC

ciclesonide; inhalant

2.7

121.2

722

2872

127

Kela drug reimbursment

Transplant complication

6.4

120.6

201

320

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

4.2

119.9

330

815

L04AD01

ATC

ciclosporin; systemic

5.8

118.2

221

394

WX892

NOMESCO Finland

Monitored bed care

2.6

117.8

781

3273

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

4.9

115.9

262

553

R04.2

ICD-10 Finland

Haemoptysis

3.2

111.1

457

1479

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

108.0

1481

8338

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

4.4

107.7

276

645

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

104.9

1087

5511

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

103.8

1561

9054

R99

ICPC

Respiratory disease other

4.7

103.3

246

542

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.8

101.1

548

2070

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

15.9

99.2

R50.9

ICD-10 Finland

Fever, unspecified

2.0

99.1

1246

6779

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

56.5

99.1

L88

ICPC

Rheumatoid/seropositive arthritis

3.3

98.9

392

1239

R81

ICPC

Pneumonia

3.1

98.2

423

1405

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

97.2

1781

10977

WW200

NOMESCO Finland

Immunization

4.0

96.3

282

728

R4110

NOMESCO Finland

Physiotherapy

1.8

95.4

2096

13628

J67.9

ICD-10 Finland

Hypersensitivity pneumonitis due to unspecified organic dust

25.6

94.8

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

94.7

1656

10045

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

94.5

2305

15435

ZX108

NOMESCO Finland

Inhalation

8.0

94.5

128

162

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.4

93.4

742

3362

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

92.6

3345

24868

J01AA02

ATC

doxycycline; systemic

1.8

91.8

5240

44065

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

7.0

91.7

141

206

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

8.4

91.1

119

144

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.7

90.7

537

2119

J45.1

ICD-10 Finland

Nonallergic asthma

2.5

90.6

618

2612

R05

ICPC

Cough

1.8

88.5

1740

10906

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

87.6

2066

13640

XG466

NOMESCO Finland

Sleep oxymetry

3.4

86.4

327

1003

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

3.4

86.3

317

954

R28

ICPC

Limited function/disability (R)

4.8

86.1

197

420

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

84.8

1669

10444

WX726

NOMESCO Finland

High-flow oxygen therapy

17.6

83.5

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.5

83.1

558

2338

GX2C5

NOMESCO Finland

Short-lasting oximetry

8.9

82.9

103

117

J01FA06

ATC

roxithromycin; oral

1.7

82.7

2644

18867

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

6.2

82.1

140

228

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

81.9

1123

6258

H02AB07

ATC

prednisone; oral

2.0

78.9

1068

5919

N02AA01

ATC

morphine; systemic, rectal

3.6

77.7

264

755

L04AD02

ATC

tacrolimus; systemic

6.9

77.3

119

174

XX2RW, ,

NOMESCO Finland

4.7

76.4

177

381

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

75.7

1443

8902

GDA10

NOMESCO Finland

Biopsy of lung

16.1

75.3

D86.0

ICD-10 Finland

Sarcoidosis of lung

5.5

75.2

145

266

XX9XE

NOMESCO Finland

Other ultrasound examination

7.1

74.4

112

160

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.5

73.6

511

2171

J43.8

ICD-10 Finland

Other emphysema

10.8

73.2

L04AA24

ATC

abatacept; parenteral

11.7

73.1

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.6

72.5

248

712

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

13.0

69.9

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

69.6

1052

6027

ZXE00

NOMESCO Finland

One hour or less

1.6

69.5

2566

18744

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.8

68.9

349

1267

NH3EA

NOMESCO Finland

Feet X-ray examination with load

4.1

68.1

190

473

ZX120

NOMESCO Finland

Intravenous

2.1

66.9

751

3882

N02AX02

ATC

tramadol; systemic, rectal

1.6

66.7

3017

23024

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

23.0

66.1

120

Kela drug reimbursment

Hypogammaglobulinaemia

23.7

65.4

J01CA04

ATC

amoxicillin; systemic

1.6

64.6

5120

44230

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

64.3

1231

7562

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

7.4

63.9

125

Z3226

NOMESCO Finland

Physiotherapist

1.7

63.3

1294

8095

F1246, ,

NOMESCO Finland

16.9

62.6

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

62.4

2464

18158

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

3.9

61.9

185

484

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

61.7

778

4186

JN4AD

NOMESCO Finland

Body CT examination

1.8

61.5

998

5829

L04AB01

ATC

etanercept; parenteral

4.9

61.5

135

278

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

10.4

61.4

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

61.0

1280

8057

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

60.5

964

5597

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

14.7

60.5

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.5

60.2

210

611

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

59.9

841

4688

M34.1

ICD-10 Finland

CR(E)ST syndrome

9.5

59.5

L04AA01

ATC

[U] ciclosporin

4.5

59.4

145

326

M01CB01

ATC

sodium aurothiomalate; parenteral

4.4

59.2

148

339

J43.2

ICD-10 Finland

Centrilobular emphysema

8.5

58.3

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

26.8

58.2

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

14.0

57.9

A03

ICPC

Fever

1.8

57.8

954

5594

I50.0

ICD-10 Finland

Congestive heart failure

1.9

57.8

786

4334

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

24.3

57.6

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

18.9

57.0

R03BA02

ATC

budesonide; inhalant

1.7

56.2

1139

7083

C07AB07

ATC

bisoprolol; oral

1.5

55.0

3741

30637

J84

ICD-10 Finland

Other interstitial pulmonary diseases

542.5

54.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

54.4

774

4325

J92.9

ICD-10 Finland

Pleural plaque without asbestos

4.1

53.6

151

379

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

53.4

2045

14844

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.3

53.4

209

654

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

53.2

533

2632

A02BC05

ATC

esomeprazole; systemic

1.5

52.8

2630

20167

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

52.7

987

5994

A02BC01

ATC

omeprazole; systemic

1.5

52.6

1915

13740

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

6.0

52.5

154

F2680, ,

NOMESCO Finland

13.8

51.9

Z51.5

ICD-10 Finland

Palliative care

1.8

51.1

833

4853

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

51.0

620

3284

Z2221

NOMESCO Finland

Medical doctor

1.6

50.9

1745

12338

M05BA07

ATC

risedronic acid; oral

2.7

50.7

273

1022

A07AA02

ATC

nystatin; oral

2.2

50.7

477

2298

L04AB04

ATC

adalimumab; parenteral

3.9

50.5

152

400

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

11.1

50.2

Z3231

NOMESCO Finland

Registered nurse

1.5

49.9

1871

13482

J80

ICD-10 Finland

Adult respiratory distress syndrome

8.5

49.7

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

49.7

1634

11432

R03BA05

ATC

fluticasone; inhalant

1.7

49.6

1115

7110

5AB14, ,

NOMESCO Finland

20.1

49.5

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.3

49.4

189

583

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

3.5

49.1

175

516

GX2D5

NOMESCO Finland

Sleep oximetry

6.5

48.8

122

Z57.2

ICD-10 Finland

Occupational exposure to dust

7.5

48.3

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.6

48.2

162

460

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.1

47.5

466

2281

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

47.1

367

1636

M35.1

ICD-10 Finland

Other overlap syndromes

7.7

47.1

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

6.7

47.0

111

G47.3

ICD-10 Finland

Sleep apnoea

1.6

46.9

1481

10246

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

46.9

2762

21735

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

5.5

46.3

163

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.5

46.0

296

1211

J01FA10

ATC

azithromycin; systemic

1.4

45.7

3078

24797

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.9

45.7

226

809

WZC30

NOMESCO Finland

Teaching

1.6

45.7

1169

7689

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

45.2

649

3628

J96.0

ICD-10 Finland

Acute respiratory failure

3.6

45.1

153

437

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

8.6

44.7

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.0

44.7

530

2780

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.7

44.0

984

6249

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

10.3

44.0

M05.1

ICD-10 Finland

Rheumatoid lung disease

118.3

43.8

R03BA01

ATC

beclometasone; inhalant

1.7

43.8

922

5763

J12.8

ICD-10 Finland

Other viral pneumonia

4.6

43.5

103

226

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

43.3

903

5629

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

43.3

730

4286

R03DC03

ATC

montelukast; oral

1.7

43.0

929

5845

XPX04

NOMESCO Finland

Angioscopy

10.5

42.8

J01FF01

ATC

clindamycin; systemic

1.5

42.1

1707

12421

XJC10

NOMESCO Finland

Oesophageal pH monitoring

6.2

41.9

115

M13.9

ICD-10 Finland

Arthritis, unspecified

2.0

41.8

510

2700

M34.0

ICD-10 Finland

Progressive systemic sclerosis

14.1

41.6

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

4.0

41.6

118

298

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.9

40.9

121

315

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

40.8

402

1969

WZA10

NOMESCO Finland

Extensive medical or dental certificate

4.2

40.7

110

268

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

40.5

297

1289

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.3

39.6

300

1321

D07AC01

ATC

betamethasone; topical

1.4

39.5

2325

18129

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

4.7

39.3

196

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

4.9

39.0

174

R06AE07

ATC

cetirizine; oral

1.4

38.9

2424

19084

J99.1*M35.0

ICD-10 Finland

Respiratory disorders in sicca syndrome [Sjögren]

196.1

37.8

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.7

37.7

191

M04AA01

ATC

allopurinol; systemic

1.6

37.5

1126

7657

E0000UV, ,

ATC

1.4

37.4

2540

20259

J20

ICD-10 Finland

Acute bronchitis

1.8

37.2

635

3734

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

36.3

1161

8000

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

36.3

473

2557

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

36.2

464

2495

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

36.0

2259

17744

TGD00

NOMESCO Finland

Needle biopsy of lung

5.5

35.7

127

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

35.4

325

1548

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.2

35.3

311

1457

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.5

35.2

232

960

A02BC03

ATC

lansoprazole; oral

1.4

35.1

1865

14209

R06.2

ICD-10 Finland

Wheezing

2.2

34.9

300

1393

RS123, ,

NOMESCO Finland

13.3

34.8

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

3.6

34.8

117

333

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

95.6

34.7

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

34.6

2540

20453

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

34.4

2027

15719

J01DB01

ATC

cefalexin; oral

1.4

34.2

5178

46897

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

12.2

34.1

C01DA14

ATC

isosorbide mononitrate; oral

1.5

33.9

1399

10148

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.1

33.9

225

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

7.2

33.9

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.1

33.7

318

1531

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

5.3

33.6

127

L01AA01

ATC

cyclophosphamide; systemic

5.7

33.4

110

J94.1

ICD-10 Finland

Fibrothorax

38.4

33.3

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

33.2

458

2520

M33.2

ICD-10 Finland

Polymyositis

7.9

33.2

Z2446

NOMESCO Finland

Social worker

2.0

33.1

391

2043

N03AX16

ATC

[U] pregabalin

1.5

32.7

1445

10617

H02AB04

ATC

methylprednisolone; systemic

1.6

32.6

896

5955

J67.0

ICD-10 Finland

Farmer lung

9.5

32.4

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

32.3

685

4269

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

6.2

32.2

1XC02, ,

NOMESCO Finland

4.7

32.1

159

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.7

31.9

156

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

31.9

2395

19281

J99.0

ICD-10 Finland

Rheumatoid lung disease

318.6

31.9

JN4BD

NOMESCO Finland

Extensive body CT

1.6

31.8

758

4868

XG460

NOMESCO Finland

Short time oxymetry

3.0

31.7

143

487

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.0

31.7

343

1739

M33.1

ICD-10 Finland

Other dermatomyositis

12.5

31.5

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

31.5

2268

18128

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

31.4

2776

22913

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.4

31.1

114

343

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

4.0

31.1

222

XG405

NOMESCO Finland

Education on PEF monitoring

3.2

30.7

123

391

H02AB09

ATC

hydrocortisone; systemic

2.7

30.4

169

644

M81.4

ICD-10 Finland

Drug-induced osteoporosis

5.1

30.3

124

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

4.8

30.1

140

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

11.5

30.0

N02BE01

ATC

paracetamol; systemic, rectal

1.5

29.9

5779

53812

WX722

NOMESCO Finland

PEEP

2.0

29.9

337

1733

SPAT1262

SPAT

Handing over of treatment supplies

1.5

29.8

1231

8908

A01AB09

ATC

miconazole; local oral

1.7

29.5

549

3300

1CX01, ,

NOMESCO Finland

10.7

29.5

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.7

29.3

160

604

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

29.2

897

6102

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.5

29.1

180

723

GAA31

NOMESCO Finland

Thoracoscopy

5.9

29.1

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

29.1

1589

12096

R03AK11

ATC

formoterol and fluticasone; inhalant

2.6

28.4

168

660

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.6

28.4

165

643

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

28.3

999

6997

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

28.3

798

5324

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.3

28.0

103

311

SPAT1325

SPAT

Vaccination

1.4

28.0

2274

18437

J01FA15

ATC

telithromycin; oral

1.7

27.9

536

3249

R4190

NOMESCO Finland

Nutritional therapy

2.2

27.9

237

1095

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.0

27.9

289

1442

J18

ICD-10 Finland

Pneumonia, organism unspecified

3.6

27.8

250

AN1

Coronary angiography

1.5

27.8

903

6214

R29

ICPC

Respiratory symptom/complaint other

1.8

27.7

426

2423

J01FA09

ATC

clarithromycin; systemic

1.4

27.7

1647

12699

ZXA10

NOMESCO Finland

Bilateral

1.4

27.7

1222

8938

J45.8

ICD-10 Finland

Mixed asthma

2.3

27.7

214

951

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

27.5

1525

11621

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.4

27.4

192

817

2AX04, ,

NOMESCO Finland

47.3

27.4

N02AA05

ATC

oxycodone; systemic

1.4

27.4

1400

10517

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

27.3

1131

8174

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

27.3

4146

36744

SPAT1263

SPAT

Sampling

1.3

27.2

2526

20870

J98.4

ICD-10 Finland

Other disorders of lung

7.6

27.2

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

27.0

844

5758

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

8.4

27.0

L04AB06

ATC

golimumab; parenteral

5.0

27.0

114

J05AB11

ATC

valaciclovir; oral

1.5

26.7

852

5836

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.8

26.6

131

469

J93.8

ICD-10 Finland

Other pneumothorax

4.8

26.6

127

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

26.3

1199

8816

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.7

26.3

146

557

I73.0

ICD-10 Finland

Raynaud syndrome

3.1

25.9

107

347

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

25.8

385

2170

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

25.7

2324

19078

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

25.7

399

2276

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.3

25.7

151

M31.3

ICD-10 Finland

Wegener granulomatosis

5.9

25.7

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

4.5

25.4

136

J15.8

ICD-10 Finland

Other bacterial pneumonia

3.6

25.2

224

WPA11

NOMESCO Finland

Developing a plan for palliative care

6.0

25.1

RK110, ,

NOMESCO Finland

3.9

25.1

193

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

25.0

1711

13459

5169X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy

+∞

25.0

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.9

24.9

185

RK320, ,

NOMESCO Finland

3.6

24.8

222

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

24.6

329

1791

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

24.6

1577

12271

L04AC07

ATC

tocilizumab; parenteral

6.6

24.6

B01AA03

ATC

warfarin; systemic

1.4

24.5

1547

12010

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

24.3

387

2224

A10AC01

ATC

insulin (human); parenteral

1.7

24.3

512

3180

WX872

NOMESCO Finland

Intensive care

1.8

24.2

376

2145

L04AB05

ATC

certolizumab pegol; parenteral

6.9

24.1

N03AX12

ATC

[U] gabapentin; oral

1.5

24.1

969

6948

WPA13

NOMESCO Finland

Palliative consultation

4.4

24.0

138

3A006, ,

NOMESCO Finland

+∞

24.0

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

4.1

23.9

164

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.3

23.9

184

817

N05CF01

ATC

zopiclone; oral

1.3

23.9

2068

16830

L04AA17

ATC

[U] adalimumab

6.8

23.7

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

23.7

1085

7967

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

6.2

23.6

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.8

23.6

390

2266

R03BB07

ATC

umeclidinium bromide; inhalant

3.5

23.5

230

WX723

NOMESCO Finland

CPAP therapy

2.0

23.5

251

1266

3006

Kela drug reimbursment

Baricitinib

9.4

23.5

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.3

23.5

171

741

318

Kela drug reimbursment

Teriparatide

4.4

23.3

133

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

23.3

1509

11747

5BA08, ,

NOMESCO Finland

4.4

23.3

129

H05AA02

ATC

teriparatide; parenteral

4.6

23.3

117

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

23.3

530

3356

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.4

23.2

153

634

L04AA37

ATC

[U] baricitinib

9.7

23.2

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.2

23.1

297

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.3

22.9

172

755

5163A

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis

+∞

22.9

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

3.4

22.9

234

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

6.9

22.9

J46

ICD-10 Finland

Status asthmaticus

2.2

22.9

186

845

UJF32

NOMESCO Finland

Coloscopy

1.3

22.8

1752

13989

R01AD09

ATC

mometasone; nasal

1.3

22.8

2314

19225

D07AC13

ATC

mometasone; topical

1.3

22.7

1672

13265

J05AB01

ATC

aciclovir; systemic

1.4

22.7

1238

9365

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

1.9

22.5

303

1653

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

4.1

22.5

154

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

3.0

22.5

100

339

291

Kela drug reimbursment

Tofacitinib

7.9

22.1

R74

ICPC

Upper respiratory infection acute

1.4

22.1

1355

10448

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

22.0

486

3052

XA421

NOMESCO Finland

Nocturnal polygraphy

5.0

22.0

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

21.9

651

4384

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

21.8

335

1905

1240

FHL

Bronchoscopy

3.0

21.7

314

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

21.7

868

6211

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

21.5

642

4325

R01AD08

ATC

fluticasone; nasal

1.4

21.4

1430

11163

J01MA02

ATC

ciprofloxacin; systemic

1.3

21.4

2560

21687

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

21.0

1294

9975

R24

ICPC

Haemoptysis

3.5

20.9

204

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

20.9

212

1050

R01AD12

ATC

fluticasone furoate; nasal

1.4

20.9

1415

11065

WX002

NOMESCO Finland

Sedation and analgesia

1.4

20.8

1224

9360

WX882

NOMESCO Finland

High dependency care

2.1

20.7

198

960

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

20.6

349

2043

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

2.7

20.5

106

390

WX402

NOMESCO Finland

General anaesthesia

1.4

20.5

1216

9309

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

3.4

20.5

212

J02AC01

ATC

fluconazole; systemic

1.3

20.5

1816

14763

C09AA05

ATC

ramipril; oral

1.3

20.4

1824

14838

A10AB05

ATC

insulin aspart; parenteral

1.6

20.4

496

3188

C03DA01

ATC

spironolactone; oral

1.4

20.4

885

6424

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.8

20.4

320

1832

M05BX04

ATC

denosumab; parenteral

1.6

20.3

441

2758

XQ800

NOMESCO Finland

Prick test

1.8

20.3

313

1782

R76.0

ICD-10 Finland

Raised antibody titre

6.1

20.3

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

20.2

532

3486

R03BB01

ATC

ipratropium bromide; inhalant

1.8

20.1

296

1662

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

20.1

551

3643

XF402

NOMESCO Finland

ECG with work load test

1.5

20.0

720

5041

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.2

19.9

161

730

J02AC03

ATC

voriconazole; systemic

6.3

19.7

132

Kela drug reimbursment

Sarcoidosis

3.9

19.7

147

ZXA00

NOMESCO Finland

Right side

1.3

19.7

1685

13618

ZXD05

NOMESCO Finland

Urgent procedure

1.3

19.7

1778

14477

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

19.6

204

1021

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

6.8

19.5

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

24.6

19.5

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.9

19.4

254

1375

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

19.4

349

2078

XF622

NOMESCO Finland

Measurement of minute volume of heart

5.1

19.3

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

2.5

19.2

115

456

J98.9

ICD-10 Finland

Respiratory disorder, unspecified

6.5

19.2

B02.9

ICD-10 Finland

Zoster without complication

1.6

19.2

470

3028

R03AC13

ATC

formoterol; inhalant

1.8

19.1

310

1791

I27.0

ICD-10 Finland

Primary pulmonary hypertension

6.7

19.1

R03DA04

ATC

theophylline; systemic, rectal

1.7

19.1

378

2308

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.1

19.1

179

862

L04AA29

ATC

[U] tofacitinib

6.9

19.1

R03AC12

ATC

salmeterol; inhalant

1.8

19.1

303

1741

J96.9

ICD-10 Finland

Respiratory failure, unspecified

3.5

18.9

189

J01DA01

ATC

[U] cefalexin

1.3

18.8

3618

32277

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.0

18.7

207

1059

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

18.6

1820

14953

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

18.6

325

1919

R03AC03

ATC

terbutaline; inhalant

1.5

18.5

735

5241

GD1AA, ,

SPAT

1.5

18.4

694

4899

L01CB

ATC

Podophyllotoxin derivatives

6.2

18.4

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

5.2

18.4

M10.9

ICD-10 Finland

Gout, unspecified

1.5

18.4

549

3697

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.7

18.3

357

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

7.8

18.3

SPAT1255

SPAT

Intravenous administration of medicine

1.6

18.3

449

2894

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

18.2

2566

22048

M05BA06

ATC

ibandronic acid; systemic

2.3

18.2

134

585

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.5

18.2

538

3616

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.1

18.1

176

859

J94.8

ICD-10 Finland

Other specified pleural conditions

2.3

18.1

136

599

N07BA03

ATC

varenicline; oral

1.9

18.0

213

1116

GDA97

NOMESCO Finland

Other thoracoscopic incision, excision of lesion or repair of lung

52.6

17.9

A28

ICPC

Limited function/disability NOS

1.3

17.9

1389

11049

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

5.8

17.9

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

3.1

17.9

231

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

17.8

1062

8120

GD1CQ

NOMESCO Finland

Lung circulation SPECT with low dose CT

6.7

17.8

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

17.8

485

3201

NDG30

NOMESCO Finland

Fusion of wrist, total

4.3

17.8

105

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.7

17.7

337

2038

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.3

17.6

137

613

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

17.5

988

7488

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

17.5

570

3909

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

17.5

464

3045

6BA02, ,

NOMESCO Finland

6.5

17.4

M25.5

ICD-10 Finland

Pain in joint

1.3

17.2

1693

13894

ED1AA

NOMESCO Finland

Mandibular X-ray examination

3.7

17.2

143

R03AC19

ATC

olodaterol

4.2

17.1

108

R2110

NOMESCO Finland

Giving the first information

1.7

17.1

323

1947

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

17.1

1782

14729

XX3DW

NOMESCO Finland

Time consuming IT work

1.4

17.1

679

4839

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

17.1

1731

14256

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

5.0

17.1

A46

ICD-10 Finland

Erysipelas

1.4

17.0

1007

7687

TNG10

NOMESCO Finland

Puncture of knee

2.9

17.0

281

J99.1*M33.2

ICD-10 Finland

Respiratory disorders in polymyositis

50.1

17.0

SPAT1260

SPAT

Consultation of another employee

1.4

16.9

1039

7975

M01CB03

ATC

auranofin; oral

3.4

16.8

174

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

3.5

16.7

160

B01AC04

ATC

clopidogrel; oral

1.3

16.7

1263

10002

J45

ICD-10 Finland

Asthma

1.5

16.6

524

3567

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

4.2

16.6

102

L95

ICPC

Osteoporosis

1.8

16.6

256

1459

D07AB08

ATC

desonide; topical

1.5

16.5

592

4139

3AC01, ,

NOMESCO Finland

3.1

16.4

227

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

17.9

16.4

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

16.4

1948

16349

ZY010

NOMESCO Finland

Hospital outpatient

1.9

16.3

215

1167

ZXA05

NOMESCO Finland

Left side

1.3

16.3

1533

12493

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

16.3

824

6129

WVA20

NOMESCO Finland

Medicine administration

2.0

16.2

181

929

E000001, ,

ATC

1.3

16.1

1036

8003

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.1

16.1

145

688

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

3.2

16.1

189

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.2

16.0

140

657

B01AB05

ATC

enoxaparin; parenteral

1.3

16.0

1979

16681

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

15.9

251

1440

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

15.9

711

5177

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

15.9

199

1063

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

3.6

15.8

147

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.8

15.8

250

1436

C08CA05

ATC

nifedipine; systemic

1.6

15.7

419

2751

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.9

15.6

201

1084

J01XB01

ATC

colistin; inhalant, parenteral

26.3

15.6

ZX114

NOMESCO Finland

Intramuscular

2.7

15.5

312

L04AK01

ATC

leflunomide; oral

3.8

15.5

121

AK3

BLTX (both lung transplants)

160.4

15.5

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.3

15.5

112

486

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.4

15.4

159

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.9

15.4

117

A41.9

ICD-10 Finland

Sepsis, unspecified

1.7

15.4

256

1491

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.5

15.4

372

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

2.7

15.3

286

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

15.3

333

2084

Angiography of the heart and coronary arteries

1.5

15.2

488

3333

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.2

15.2

129

598

J98.2

ICD-10 Finland

Interstitial emphysema

11.2

15.2

R4120

NOMESCO Finland

Occupational therapy

1.6

15.2

369

2371

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

15.2

139

664

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.0

15.2

222

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

15.1

403

2648

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.4

15.0

152

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

15.0

1958

16584

M54.5

ICD-10 Finland

Low back pain

1.3

14.9

1932

16341

ZYC01

NOMESCO Finland

Remote contact by phone

1.6

14.9

317

1972

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

5.8

14.9

B01AB04

ATC

dalteparin; parenteral

1.6

14.9

318

1981

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

14.9

2123

18155

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

14.8

232

1330

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

2.6

14.7

309

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

3.6

14.7

135

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

14.7

1239

9936

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.5

14.7

368

H26.3

ICD-10 Finland

Drug-induced cataract

3.7

14.7

126

J01GB01

ATC

tobramycin; inhalant, parenteral

13.2

14.7

XX1AW

NOMESCO Finland

Written report from X-ray examination without contrast peformed elsewhere

4.1

14.6

D07AD01

ATC

clobetasol; topical

1.3

14.6

907

6965

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.4

14.6

155

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

2.3

14.5

108

475

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.7

14.5

272

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

4.4

14.5

C10AA03

ATC

pravastatin; oral

1.5

14.5

503

3493

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.3

14.4

105

457

R03BB06

ATC

glycopyrronium bromide; inhalant

3.8

14.4

114

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

14.4

488

3374

NG1DA

NOMESCO Finland

X-ray of knees

2.2

14.3

118

541

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

14.3

421

2824

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

14.3

696

5140

XX1VW

NOMESCO Finland

Written report from radiologist

3.0

14.3

198

-1, ,

NOMESCO Finland

1.3

14.2

1566

12982

D07XC01

ATC

betamethasone; topical

1.4

14.2

706

5229

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

11.3

14.2

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

11.3

14.2

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

14.2

502

3496

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

2.5

14.2

362

293

Kela drug reimbursment

Baricitinib

10.4

14.2

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

14.1

2471

21566

R01AD58

ATC

fluticasone, combinations; nasal

1.3

14.1

1012

7933

SBA10

NOMESCO Finland

Measurement of salivary flow rate

2.9

14.1

226

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

3.1

14.1

189

E84.0

ICD-10 Finland

Cystic fibrosis with pulmonary manifestations

42.6

14.1

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

3.3

14.0

154

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

14.0

184

999

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.3

14.0

100

432

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

14.0

579

4155

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.4

13.9

402

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

3.5

13.9

131

ZX100

NOMESCO Finland

Oral

2.3

13.9

100

434

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.9

13.8

184

1003

NDL52

NOMESCO Finland

Tenosynovectomy of hand

3.3

13.8

151

L04AA11

ATC

[U] etanercept

4.7

13.7

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

13.7

255

1533

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

13.7

241

1427

WX780

NOMESCO Finland

Remote monitoring CPAP

1.7

13.6

228

1332

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.6

13.6

315

2003

E84.9

ICD-10 Finland

Cystic fibrosis, unspecified

75.3

13.6

I50

ICD-10 Finland

Heart failure

1.7

13.5

243

1447

A02BA03

ATC

famotidine; systemic

1.7

13.5

241

1433

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

4.5

13.5

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

2.9

13.5

210

M06

ICD-10 Finland

Other rheumatoid arthritis

3.3

13.5

153

S97

ICPC

Chronic ulcer skin

1.5

13.5

447

3076

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

2.7

13.4

272

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

4.2

13.4

J94.9

ICD-10 Finland

Pleural condition, unspecified

3.4

13.4

139

L01BB01, ,

ATC

6.1

13.4

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

2.8

13.3

239

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

13.3

517

3667

T86.8

ICD-10 Finland

Failure and rejection of other transplanted organs and tissues

21.2

13.3

WX720

NOMESCO Finland

Own respiration

1.6

13.3

283

1762

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

3.5

13.3

130

R04.0

ICD-10 Finland

Epistaxis

1.4

13.3

526

3746

L03

ICPC

Low back symptom/complaint

1.3

13.2

1531

12753

A02BA02

ATC

ranitidine; systemic

1.3

13.2

1184

9560

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

3.0

13.2

197

WX727

NOMESCO Finland

Estimation of exercise oxygen therapy

40.1

13.1

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.7

13.1

224

1316

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.6

13.1

215

3571

C02KX04

ATC

macitentan; oral

15.0

13.1

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

6.1

12.9

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.6

12.9

266

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

4.2

12.9

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

50.1

12.8

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.8

12.8

180

999

D11

ICPC

Diarrhoea

1.4

12.8

531

3812

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

12.7

223

1320

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

12.7

343

2259

B07.9

ICD-10 Finland

Verruca simplex

1.8

12.6

173

953

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.2

12.6

101

459

WPB10

NOMESCO Finland

Making a convalescent care decision

3.5

12.6

125

OAB50, ,

SPAT

1.4

12.6

495

3519

XG422

NOMESCO Finland

Time-volume spirometry with bronchodialtation

6.0

12.6

H03AA01

ATC

levothyroxine sodium; systemic

1.3

12.6

1196

9723

TK800

NOMESCO Finland

Hemodialysis

2.0

12.6

136

693

J99.1*M34.8

ICD-10 Finland

Respiratory disorders in systemic: sclerosis

32.1

12.6

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

1.8

12.6

178

991

XF404

NOMESCO Finland

Ambulatory ECG

1.4

12.6

548

3970

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.5

12.5

305

I50.1

ICD-10 Finland

Left ventricular failure

1.5

12.5

374

2518

2770A

ICD-9 Finland

Other and unspecified disorders of metabolism, Cystic fibrosis

+∞

12.5

SBA00

NOMESCO Finland

Microbiological examinations

1.9

12.5

142

736

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

12.5

246

1503

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

12.5

881

6885

WX740

NOMESCO Finland

Nitrogen oxide therapy

9.3

12.4

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

3.9

12.4

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

5.0

12.4

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.6

12.4

278

1756

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

4.5

12.3

N06AX11

ATC

mirtazapine; oral

1.2

12.3

1869

16018

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.1

12.3

162

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

3.3

12.3

132

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

3.2

12.3

147

K02.1

ICD-10 Finland

Caries of dentine

1.2

12.2

2988

26832

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

3.5

12.2

118

Z94.3

ICD-10 Finland

Heart and lungs transplant status

37.6

12.2

L03AA02

ATC

filgrastim; parenteral

1.8

12.2

171

950

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

3.4

12.2

128

ZX197, ,

NOMESCO Finland

15.9

12.1

S18

ICPC

Laceration/cut

1.2

12.1

2951

26489

E000002, ,

ATC

1.4

12.1

501

3598

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.4

12.0

595

4403

C10AA01

ATC

simvastatin; oral

1.2

12.0

3003

27004

J86.9

ICD-10 Finland

Pyothorax without fistula

2.6

11.9

265

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.2

11.9

444

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.5

11.9

442

3110

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1.8

11.9

187

1075

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.8

11.8

160

878

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

11.8

1565

13209

N06DA03

ATC

rivastigmine; oral, transdermal

0.5

11.8

127

2376

R04

ICPC

Breathing problem other

1.7

11.8

217

1302

XX7LW, ,

NOMESCO Finland

5.4

11.8

N06DX01

ATC

memantine; oral

0.7

11.7

306

4569

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

5.1

11.7

M79.6

ICD-10 Finland

Pain in limb

1.2

11.7

2423

21399

R06AX27

ATC

desloratadine; oral

1.3

11.6

1208

9916

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

11.6

603

4497

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.7

11.6

234

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

2.7

11.6

223

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

11.6

214

1287

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

11.5

177

1010

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

3.2

11.5

143

M48.0

ICD-10 Finland

Spinal stenosis

1.3

11.5

818

6398

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

9.2

11.5

5168X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Other specified alveolar and parietoalveolar pneumopathies

+∞

11.5

51701

ICD-8 Finland

Other chronic interstitial pneumonia, Fibrosis interstitialis diffusa pulmonum essentialis (Hamman-Rich)

+∞

11.5

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.0

11.4

122

619

G53.0

ICD-10 Finland

Postzoster neuralgia

2.8

11.4

202

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

13.6

11.4

4040, ,

NOMESCO Finland

13.6

11.4

304

Kela drug reimbursment

Dornase alfa

120.2

11.4

R05CB13

ATC

dornase alfa (desoxyribonuclease); inhalant

120.2

11.4

R60.0

ICD-10 Finland

Localized oedema

1.3

11.4

814

6366

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

2.5

11.4

283

ZY000

NOMESCO Finland

Hospital inpatient

2.8

11.4

197

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.4

11.4

426

3002

A07EC02

ATC

mesalazine; oral, rectal

1.6

11.4

254

1603

NDF10

NOMESCO Finland

Synovectomy of wrist

5.4

11.3

RS221, ,

NOMESCO Finland

2.4

11.3

333

R4130

NOMESCO Finland

Speech therapy

1.8

11.3

162

906

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

8.9

11.2

C10AA05

ATC

atorvastatin; oral

1.2

11.2

2861

25720

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

11.2

2872

25829

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

2.5

11.2

262

RK120, ,

NOMESCO Finland

4.4

11.2

XQ848

NOMESCO Finland

Dermatological photography

1.7

11.0

182

1061

B01AF02

ATC

apixaban; oral

1.3

11.0

979

7886

R53

ICD-10 Finland

Malaise and fatigue

1.2

10.9

1432

12058

UGC02

NOMESCO Finland

Rigid bronchoscopy

4.6

10.9

D02AE01

ATC

carbamide; topical

1.5

10.9

326

2196

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.5

10.9

328

2213

I25.2

ICD-10 Finland

Old myocardial infarction

1.4

10.9

508

3724

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

10.8

3644

33522

J32.4

ICD-10 Finland

Chronic pansinusitis

2.3

10.8

340

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.5

10.8

349

2390

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.5

10.8

261

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

10.7

2145

18837

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

9.6

10.7

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

10.7

209

1276

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.9

10.7

140

762

A01AB04

ATC

amphotericin B; local oral

1.6

10.7

268

1739

A04

ICPC

Weakness/tiredness general

1.3

10.6

917

7353

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

60.1

10.6

S22.2

ICD-10 Finland

Fracture of sternum

3.0

10.6

150

J93.9

ICD-10 Finland

Pneumothorax, unspecified

3.0

10.6

145

XG420

NOMESCO Finland

Time-volume spirometry

5.3

10.6

B37.0

ICD-10 Finland

Candidal stomatitis

2.5

10.5

246

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

10.5

440

3163

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.9

10.5

136

737

DHA10

NOMESCO Finland

Biopsy of cavity of nose

2.8

10.5

178

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

4.3

10.5

J43.1

ICD-10 Finland

Panlobular emphysema

10.0

10.5

B59

ICD-10 Finland

Pneumocystosis

9.2

10.5

B34.9

ICD-10 Finland

Viral infection, unspecified

1.9

10.5

121

632

P01AB01

ATC

metronidazole; oral, rectal

1.2

10.5

2035

17817

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

10.4

2306

20424

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.8

10.4

158

900

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

2.7

10.4

196

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.8

10.4

163

938

SPAT1310

SPAT

Counselling related to known health issue

1.2

10.3

1748

15097

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.0

10.3

107

538

207

Kela drug reimbursment

Chronic arrhythmias

1.2

10.3

1188

9858

GDA21

NOMESCO Finland

Thoracoscopic excision of lesion of lung

5.1

10.3

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

10.3

493

3630

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.8

10.2

158

904

M01AE02

ATC

naproxen; oral, rectal

1.2

10.2

2950

26726

F03

ICD-10 Finland

Unspecified dementia

0.5

10.2

124

2236

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

18.8

10.2

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

3.3

10.2

117

J67.8

ICD-10 Finland

Hypersensitivity pneumonitis due to other organic dusts

23.4

10.2

D72.1

ICD-10 Finland

Eosinophilia

3.6

10.2

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

2.3

10.2

311

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.9

10.2

115

596

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

10.2

148

832

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.7

10.2

175

1033

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

10.1

472

3457

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

10.1

2146

18925

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.1

10.1

428

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

1.9

10.1

128

690

NDG74

NOMESCO Finland

Fusion of first IP joint

4.2

10.1

M10

ICD-10 Finland

Gout

1.5

10.1

299

2013

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.5

10.1

1822

SPAT1059

SPAT

Spirometry at the office

1.5

10.0

288

1925

RS230, ,

NOMESCO Finland

3.3

10.0

114

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.7

9.9

169

995

ZX121

NOMESCO Finland

Central venous catheter

3.8

9.9

M03BX02

ATC

tizanidine; oral

1.2

9.9

3179

29032

N06DA02

ATC

donepezil; oral

0.6

9.9

223

3435

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

9.9

3770

34924

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

9.9

477

3516

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.1

9.9

419

RK250, ,

NOMESCO Finland

3.1

9.9

125

S29

ICPC

Skin symptom/complaint other

1.2

9.8

1172

9756

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

3.2

9.8

115

M54

ICD-10 Finland

Dorsalgia

1.4

9.8

547

4128

L28

ICPC

Limited function/disability (L)

1.2

9.7

1278

10749

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

3.5

9.7

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.0

9.7

107

550

XX4AW, ,

NOMESCO Finland

9.5

9.7

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

9.7

175

1046

I26

ICD-10 Finland

Pulmonary embolism

2.5

9.7

244

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

1.8

9.7

129

706

M01AB05

ATC

diclofenac; systemic, rectal

1.2

9.7

3689

34140

M01AH02

ATC

rofecoxib; oral

1.3

9.7

734

5784

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.4

9.7

401

2880

R52.0

ICD-10 Finland

Acute pain

1.7

9.7

155

898

WPA44

NOMESCO Finland

Nursing home for palliative care

3.8

9.7

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

9.6

327

2262

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.4

9.6

457

3358

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

9.6

3368

30949

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

9.6

544

4113

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

5.0

9.6

D05AX52

ATC

calcipotriol, combinations; topical

1.5

9.5

272

1816

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.6

9.5

197

1221

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

15.0

9.5

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.5

9.5

280

1883

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.4

9.5

417

3027

AA1AD

NOMESCO Finland

CT of head and brain

1.2

9.4

1934

16979

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.1

9.4

440

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

3.2

9.4

113

L17

ICPC

Foot/toe symptom/complaint

1.2

9.4

1746

15191

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

9.4

813

6517

M01CC01

ATC

penicillamine; oral

5.1

9.3

D83.0

ICD-10 Finland

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

21.7

9.3

N19

ICD-10 Finland

Unspecified kidney failure

1.5

9.3

264

1760

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

9.3

2118

18761

RS220, ,

NOMESCO Finland

2.3

9.3

286

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

4.5

9.3

E000003, ,

ATC

1.6

9.3

205

1292

5010A

ICD-9 Finland

Asbestosis[ASBESTOSIS]

10.6

9.3

L57.0

ICD-10 Finland

Actinic keratosis

1.3

9.3

755

6006

Z71.8

ICD-10 Finland

Other specified counselling

1.2

9.3

1727

15029

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

2.9

9.2

146

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.6

9.2

210

1334

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

1.8

9.2

134

755

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.6

9.2

222

1429

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

9.2

1641

14221

R06AE09

ATC

levocetirizine; oral

1.3

9.2

576

4421

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.5

9.1

302

2080

SPAT1254

SPAT

Administration of medicine

1.3

9.1

889

7230

RT271, ,

NOMESCO Finland

7.7

9.1

D07BC01

ATC

betamethasone and antiseptics; topical

1.3

9.1

640

4993

D05BB02

ATC

acitretin; oral

1.8

9.1

125

693

R11

ICD-10 Finland

Nausea and vomiting

1.4

9.1

450

3333

GX1R5

NOMESCO Finland

Peak expiratory flow (PEF) measurement

11.5

9.0

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

9.0

735

5847

WNF00

NOMESCO Finland

Infection source and contact determination

3.3

9.0

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

10.0

9.0

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

1.6

9.0

181

1115

N06AA09

ATC

amitriptyline; systemic

1.3

9.0

514

3892

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.7

9.0

144

835

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.1

9.0

362

J01FA01

ATC

erythromycin; systemic

1.3

8.9

543

4148

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.1

8.9

402

A11

ICPC

Chest pain NOS

1.3

8.9

512

3878

UDC00

NOMESCO Finland

Ear microscopy

1.4

8.9

403

2938

WX213

NOMESCO Finland

Lower leg blockade

2.4

8.9

236

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.5

8.9

254

1697

I20.09

ICD-10 Finland

Unstable angina

1.4

8.9

389

2820

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

24.0

8.9

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

3.1

8.9

112

NDG76

NOMESCO Finland

Fusion of DIP joint

2.6

8.9

189

D80.0

ICD-10 Finland

Hereditary hypogammaglobulinaemia

12.5

8.8

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.5

8.8

1771

J98.6

ICD-10 Finland

Disorders of diaphragm

3.0

8.8

123

R78

ICPC

Acute bronchitis/bronchiolitis

1.9

8.8

110

591

SPAT1097

SPAT

Recording of ECG

1.3

8.8

890

7267

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.3

8.8

281

8041/3-C34.3

ICD-O-3

Small cell carcinoma, NOS, of lower lobe, lung

8.6

8.8

Coronary artery bypass surgery

1.7

8.8

166

1007

G04BE08

ATC

tadalafil; oral

4.0

8.8

M31.7

ICD-10 Finland

Microscopic polyangiitis

7.2

8.7

5110B

ICD-9 Finland

Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]

4.1

8.7

C02KX01

ATC

bosentan; oral

14.0

8.7

E84.1

ICD-10 Finland

Cystic fibrosis with intestinal manifestations

50.1

8.7

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

4.2

8.6

M02AA07

ATC

piroxicam; topical

1.2

8.6

2075

18441

XJC00

NOMESCO Finland

Oesophageal manometry

3.5

8.6

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

8.6

378

2743

3A064, ,

NOMESCO Finland

3.2

8.6

104

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

1.8

8.6

115

632

SPAT1281

SPAT

Other administrative function

1.4

8.6

401

2941

3005

Kela drug reimbursment

Tofacitinib

4.6

8.6

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.4

8.6

332

2357

A06AD11

ATC

lactulose; oral

1.2

8.6

987

8179

P70

ICPC

Dementia

0.4

8.5

1163

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

8.5

911

7489

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.5

8.5

232

1537

R03BB05

ATC

aclidinium bromide; inhalant

3.4

8.5

B48.5

ICD-10 Finland

Pneumocystosis

27.5

8.5

J70.1

ICD-10 Finland

Chronic and other pulmonary manifestations due to radiation

20.0

8.5

J70.3

ICD-10 Finland

Chronic drug-induced interstitial lung disorders

20.0

8.5

ZX140

NOMESCO Finland

Intra articular

2.6

8.5

188

T90

ICPC

Diabetes non-insulin dependent

1.2

8.4

1567

13614

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

8.4

366

2652

E84.8

ICD-10 Finland

Cystic fibrosis with other manifestations

90.2

8.4

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

4.9

8.3

C01AA05

ATC

digoxin; systemic

1.3

8.3

579

4508

51709

ICD-8 Finland

Other chronic interstitial pneumonia, Unspecified

7.8

8.3

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.2

8.3

320

UGC08

NOMESCO Finland

Rigid bronchoscopy with biopsy of lung

+∞

8.3

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

8.3

1425

12286

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

4.0

8.3

R01

ICPC

Pain respiratory system

2.0

8.3

400

WX730

NOMESCO Finland

Conventional respirator

1.9

8.3

490

U08.9

ICD-10 Finland

Personal history of COVID-19, unspecified

3.6

8.3

K08.3

ICD-10 Finland

Retained dental root

1.4

8.2

442

3314

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.3

8.2

270

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.0

8.2

463

R13

ICD-10 Finland

Dysphagia

1.4

8.2

419

3116

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

3.5

8.2

A01

ICPC

Pain general/multiple sites

1.3

8.2

549

4253

NXL00

NOMESCO Finland

Biopsy of muscle

3.3

8.2

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

3.0

8.2

118

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.0

8.2

444

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

8.1

1506

13073

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.3

8.1

516

3967

L04AC14

ATC

sarilumab; systemic

7.5

8.1

N17.8

ICD-10 Finland

Other acute renal failure

2.0

8.1

438

F2682, ,

NOMESCO Finland

4.7

8.1

M01AB55

ATC

diclofenac, combinations; oral

1.4

8.1

377

2764

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

8.1

1232

10503

B01AB10

ATC

tinzaparin; parenteral

1.3

8.1

597

4688

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.6

8.1

198

1281

FXE00

NOMESCO Finland

Use of ECLA

17.2

8.1

D83.9

ICD-10 Finland

Common variable immunodeficiency, unspecified

17.2

8.1

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

1.9

8.1

516

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

8.1

336

2418

N02BF02

ATC

pregabalin; oral

1.4

8.0

329

2359

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

1.9

8.0

531

D07AA02

ATC

hydrocortisone; topical

1.3

8.0

641

5086

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

2.3

8.0

261

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

8.0

1115

9421

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

2.9

8.0

125

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.8

8.0

120

684

XX9XW, ,

NOMESCO Finland

2.8

8.0

136

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

8.0

651

5179

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.4

8.0

218

SPAT1058

SPAT

PEF monitoring instruction

1.4

8.0

412

3073

RK310, ,

NOMESCO Finland

7.2

7.9

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

7.2

7.9

C08CA02

ATC

felodipine; oral

1.3

7.9

626

4959

R63.4

ICD-10 Finland

Abnormal weight loss

1.5

7.9

246

1675

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

7.9

1326

11404

SAA04

NOMESCO Finland

Special examination of mouth

1.5

7.9

222

1480

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.6

7.9

189

1216

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

2.4

7.9

219

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.4

7.9

384

2837

7102A

ICD-9 Finland

Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]

13.0

7.9

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

7.7

7.9

S22.3

ICD-10 Finland

Fracture of rib

1.4

7.8

409

3056

RK220, ,

NOMESCO Finland

3.5

7.8

M81.8

ICD-10 Finland

Other osteoporosis

2.2

7.8

264

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

2.9

7.8

116

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

7.8

1391

12032

M32

ICD-10 Finland

Systemic lupus erythematosus

9.4

7.8

M01AX17

ATC

nimesulide; oral

1.2

7.7

1357

11718

4038, ,

NOMESCO Finland

45.0

7.7

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

7.7

2124

19049

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.5

7.7

221

1481

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.4

7.7

321

2311

R06AX22

ATC

ebastine; oral

1.3

7.7

706

5698

J01DA06

ATC

[U] cefuroxime

1.3

7.7

685

5509

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.3

7.7

564

4426

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

7.7

712

5754

R03AC18

ATC

indacaterol; inhalant

2.3

7.6

235

WX204

NOMESCO Finland

Axillary plexus blockaced

1.6

7.6

163

1022

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.0

7.6

359

L95.8

ICD-10 Finland

Other vasculitis limited to skin

3.7

7.6

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.2

7.5

976

8182

B37.08

ICD-10 Finland

Other candidal stomatitis

2.3

7.5

230

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.6

7.5

150

924

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

3.3

7.5

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

2.8

7.5

130

SFA10

NOMESCO Finland

One-surface restoration

1.2

7.5

2775

25437

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

1.7

7.4

137

827

L01

ICPC

Neck symptom/complaint

1.3

7.4

743

6058

A07EA06

ATC

budesonide; oral, local oral

1.6

7.4

164

1037

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

7.4

131

783

M13.0

ICD-10 Finland

Polyarthritis, unspecified

2.1

7.4

303

602

Kela drug reimbursment

Children's severe malnutrition

13.4

7.4

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

3.2

7.4

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

7.4

2127

19130

UJD02

NOMESCO Finland

Gastroscopy

1.4

7.4

267

1875

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.4

7.3

361

2672

R79

ICPC

Chronic bronchitis

3.7

7.3

JN6AD

NOMESCO Finland

CT of torso and neck

1.8

7.3

102

569

UDM02

NOMESCO Finland

Sinoscopy

1.8

7.3

101

562

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.4

7.3

257

1794

B01AC06

ATC

acetylsalicylic acid; oral

1.5

7.3

233

1596

K51.8

ICD-10 Finland

Other ulcerative colitis

2.1

7.3

311

R07.3

ICD-10 Finland

Other chest pain

1.3

7.3

558

4402

M60.9

ICD-10 Finland

Myositis, unspecified

2.7

7.3

143

6BB16, ,

NOMESCO Finland

+∞

7.3

R95

ICPC

Chron obstructive pulmonary disease

1.5

7.3

196

1296

D68.8

ICD-10 Finland

Other specified coagulation defects

2.3

7.3

221

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.4

7.3

362

2684

J92

ICD-10 Finland

Pleural plaque

6.8

7.3

M10.0

ICD-10 Finland

Idiopathic gout

1.5

7.3

232

1590

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

7.2

983

8279

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

2.4

7.2

185

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

2.5

7.2

173

K59.1

ICD-10 Finland

Functional diarrhoea

1.4

7.2

289

2067

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

4.3

7.2

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

1.7

7.2

134

812

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.0

7.2

340

Z50.1

ICD-10 Finland

Other physical therapy

1.4

7.2

280

1994

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.7

7.2

132

798

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

3.9

7.1

J99.1*M33.9

ICD-10 Finland

Respiratory disorders in dermatopolymyositis

30.0

7.1

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

7.1

1695

15008

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

7.1

713

5813

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

7.1

1623

14323

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.5

7.1

236

1630

B01AE07

ATC

dabigatran etexilate; oral

1.5

7.1

239

1655

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

3.3

7.1

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

3.3

7.1

WX320

NOMESCO Finland

Spinalanesthesy

1.2

7.1

1437

12557

UJF92

NOMESCO Finland

Capsular endoscopy

1.8

7.1

103

583

N06AX21

ATC

duloxetine; oral

1.3

7.0

524

4119

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

7.0

217

1477

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

2.3

7.0

212

TKC20

NOMESCO Finland

Catheterisation of bladder

1.3

7.0

435

3334

Z31.5

ICD-10 Finland

Genetic counselling

1.6

7.0

172

1114

GX1P5

NOMESCO Finland

Nocturnal CO2 monitoring

8.8

7.0

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.4

7.0

253

1775

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

1.7

7.0

112

651

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

1.9

7.0

483

Z57.3

ICD-10 Finland

Occupational exposure to other air contaminants

3.5

7.0

K22.7

ICD-10 Finland

Barrett oesophagus

1.9

7.0

420

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

7.0

694

5654

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

7.0

690

5618

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.5

7.0

223

1530

WW300

NOMESCO Finland

Transfer of autologic stem cells

3.2

7.0

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.4

7.0

824

C10AC01

ATC

colestyramine; oral

1.7

7.0

133

812

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

4.4

6.9

I47.2

ICD-10 Finland

Ventricular tachycardia

1.7

6.9

125

751

212

Kela drug reimbursment

Gout

1.6

6.9

137

843

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

6.9

604

4843

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.0

6.9

379

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.5

6.9

181

1191

RT272, ,

NOMESCO Finland

3.7

6.9

M34

ICD-10 Finland

Systemic sclerosis

13.8

6.9

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

2.3

6.9

208

M05BB04

ATC

risedronic acid, calcium and colecalciferol, sequential; oral

4.0

6.9

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

1.7

6.9

121

723

D06BB04

ATC

podophyllotoxin; topical

1.7

6.9

129

784

M01AH05

ATC

etoricoxib; oral

1.1

6.9

3243

30165

SPAT1211

SPAT

Application of soft bandage

1.3

6.8

462

3585

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

2.9

6.8

103

A02BA04

ATC

nizatidine; systemic

1.3

6.8

429

3296

N05AX08

ATC

risperidone; systemic

0.7

6.8

285

3899

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

2.0

6.8

347

RK290, ,

NOMESCO Finland

3.8

6.8

EB1WA, ,

NOMESCO Finland

2.6

6.8

137

WW500

NOMESCO Finland

Blood transfusion

1.5

6.8

225

1555

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.8

6.8

908

10723

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

1.6

6.8

166

1077

K51.5

ICD-10 Finland

Left sided colitis

1.7

6.8

109

636

XV5WT, ,

NOMESCO Finland

40.1

6.8

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

6.7

466

3628

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

5.6

6.7

R05CB01

ATC

acetylcysteine; inhalant, oral

1.8

6.7

504

-44

ICPC

Preventive immunization/medic

1.3

6.7

473

3691

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

6.7

951

8039

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

1.7

6.7

119

712

49099

ICD-8 Finland

Bronchitis, unspecified

2.2

6.7

255

N05CD07

ATC

temazepam; oral

1.2

6.7

700

5732

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.5

6.7

175

1151

M05BA01

ATC

etidronic acid; systemic

2.6

6.7

138

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

2.1

6.7

302

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

1.5

6.7

166

1081

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.6

6.6

146

923

C01BD01

ATC

amiodarone; systemic

1.5

6.6

181

1202

Z01.2

ICD-10 Finland

Dental examination

1.2

6.6

2216

20110

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.3

6.6

467

3646

M05.0

ICD-10 Finland

Felty syndrome

6.4

6.6

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.3

6.6

382

2900

RK520, ,

NOMESCO Finland

3.0

6.6

RS224, ,

NOMESCO Finland

3.0

6.6

NCB20

NOMESCO Finland

Primary total prosthetic replacement of elbow joint

5.5

6.6

J01DA08

ATC

[U] cefaclor

1.3

6.6

358

2694

X58

ICD-10 Finland

Exposure to other specified factors

1.2

6.6

669

5465

R51.80

ICD-10 Finland

Headache

1.3

6.6

650

5293

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

2.7

6.6

128

XG430

NOMESCO Finland

Spiroegometry

8.7

6.5

C61

ICD-10 Finland

Malignant neoplasm of prostate

0.8

6.5

484

6102

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.7

6.5

119

718

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

1.7

6.5

117

703

K76.9

ICD-10 Finland

Liver disease, unspecified

2.0

6.5

339

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.7

6.5

123

749

TEA00

NOMESCO Finland

Biopsy of lip

2.1

6.5

259

M01AH01

ATC

celecoxib; oral

1.2

6.5

943

7993

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

1.6

6.5

135

843

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

1.9

6.5

410

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

6.5

1264

11004

A04AA01

ATC

ondansetron; systemic, rectal

1.3

6.4

415

3201

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

6.4

291

2127

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.9

6.4

362

RD210, ,

NOMESCO Finland

1.9

6.4

390

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

1.9

6.4

383

T92

ICPC

Gout

1.6

6.4

139

877

N06AX16

ATC

venlafaxine; oral

1.3

6.4

547

4378

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.5

6.4

216

1500

K29.7

ICD-10 Finland

Gastritis, unspecified

1.5

6.4

191

1295

G44.2

ICD-10 Finland

Tension-type headache

1.3

6.4

569

4579

J21.99

ICD-10 Finland

Acute bronchiolitis, unspecified

3.7

6.4

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

1.4

6.3

310

2295

ZXD20

NOMESCO Finland

Day surgery

1.3

6.3

607

4924

M05BX03

ATC

strontium ranelate; oral

2.5

6.3

148

OAA67, ,

SPAT

0.7

6.3

236

3288

E66.8

ICD-10 Finland

Other obesity

1.5

6.3

190

1289

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.2

6.3

942

8004

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

3.6

6.3

NDF60

NOMESCO Finland

Operation for osteochondritis of a joint of hand,v

3.6

6.3

C83.1

ICD-10 Finland

Mantle cell lymphoma

2.8

6.3

108

K77

ICPC

Heart failure

1.5

6.3

160

1047

5823

FHL

Lung avobiopsy and wedge resection

5.9

6.3

D84.9

ICD-10 Finland

Immunodeficiency, unspecified

9.2

6.3

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.4

6.3

239

1696

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

3.3

6.3

XG413

NOMESCO Finland

Spirometry with oscillometry

18.0

6.3

GDB10

NOMESCO Finland

Wedge resection of lung

3.8

6.2

E000007, ,

ATC

1.4

6.2

215

1498

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.3

6.2

452

3543

K11.2

ICD-10 Finland

Sialoadenitis

1.6

6.2

149

962

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

1.8

6.2

495

SPAT1229

SPAT

Assessment of need for aid

1.3

6.2

457

3589

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

0.8

6.2

461

5809

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.5

6.2

154

1003

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.6

6.2

141

900

A91

ICPC

Abnormal result investigation NOS

1.4

6.2

286

2099

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

3.1

6.2

R07.1

ICD-10 Finland

Chest pain on breathing

1.9

6.2

374

ECB20

NOMESCO Finland

Oral alveoplasty

2.0

6.2

305

KMAK, ,

NOMESCO Finland

1.1

6.2

2423

22210

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

6.3

6.1

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.5

6.1

157

1029

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

1.8

6.1

475

C07AB02

ATC

metoprolol; systemic

1.2

6.1

1309

11476

I20.0

ICD-10 Finland

Unstable angina

2.0

6.1

306

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.5

6.1

155

1015

GDC00

NOMESCO Finland

Lobectomy of lung

2.3

6.1

188

WW409

NOMESCO Finland

Other aferesis

3.8

6.1

SPAT1301

SPAT

No procedures

1.2

6.1

1807

16243

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.5

6.1

177

1194

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

2.4

6.0

170

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

2.2

6.0

208

L02

ICPC

Back symptom/complaint

1.3

6.0

422

3294

K74.3

ICD-10 Finland

Primary biliary cirrhosis

2.5

6.0

134

TQW80

NOMESCO Finland

Local dermatologic skincare

1.6

6.0

139

891

N02BF01

ATC

gabapentin; oral

1.3

6.0

513

4106

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

6.0

453

3570

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

3565

20237

2.61

319.99

6.2

4.5

—

(3000494) Fungus identified in Specimen by Culture

1772

7121

3.02

312.86

2.3

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

712

1157

6.76

307.65

12.1

4.6

1256.62

1754.93

iu/ml

0.12

167

158

(42529582) MDA5 Ab [Presence] in Serum by Line blot

324

125

27.17

307.65

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2259

8595

3.44

307.65

2.7

1.9

—

(3013637) Mi-2 Ab [Presence] in Serum

324

125

27.17

307.65

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

864

1128

8.63

307.65

2.3

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1173

1636

8.46

307.65

2.3

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2079

8674

3.02

307.65

9.7

7.4

5.02

5.08

kpa

1.81

2013

8329

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

517

711

7.79

307.65

1.2

1.1

30.62

7.07

u/ml

1.53

(3018010) Neutrophils/Leukocytes in Blood

4953

27935

3.88

307.65

13.3

6.2

60.33

58.48

22.42

4900

26491

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

963

402

27.76

307.65

2.1

1.4

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1493

4522

3.95

307.65

2.1

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

935

1340

7.94

307.65

1.4

1.2

6.64

5.24

u/ml

0.16

117

127

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

378

375

10.62

307.65

2.0

1.4

—

(3019069) Monocytes/Leukocytes in Blood

5005

28149

3.98

307.65

13.8

6.3

9.01

9.16

3.35

4927

26147

(3019198) Lymphocytes [#/volume] in Blood

5312

30907

4.34

307.65

13.2

6.1

1.90

1.86

e9/l

0.67

4892

26654

(3028026) IgM [Mass/volume] in Serum or Plasma

1290

3445

4.39

307.65

2.3

1.9

1.12

1.38

g/l

4.58

1212

3114

(3006315) Basophils [#/volume] in Blood

5301

30420

4.42

307.65

13.0

6.0

0.04

e9/l

6.85

4823

25640

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

692

816

9.33

307.65

2.3

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

591

753

8.50

307.65

2.6

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

591

753

8.50

307.65

2.6

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

594

997

6.43

307.65

1.4

1.2

56.93

45.57

u/ml

0.66

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

948

1424

7.58

307.65

1.4

1.2

41.78

47.93

u/ml

0.19

(3039162) Centromere protein B Ab [Units/volume] in Serum

447

571

8.31

307.65

1.3

1.2

59.18

52.40

u/ml

0.15

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

324

125

27.17

307.65

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1305

1472

10.74

307.65

1.9

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

377

179

22.24

307.65

1.9

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1636

2482

8.37

307.65

3.1

2.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

806

1608

5.55

307.65

1.9

1.5

1.19

1.18

g/l

0.51

784

1529

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1061

1736

7.06

307.65

1.7

1.4

14.36

16.30

iu/ml

0.15

(44790047) Parainfluenza type 1 nucleic acid detection

591

753

8.50

307.65

2.6

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1175

1345

10.36

307.65

2.1

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

591

753

8.50

307.65

2.6

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

704

1174

6.58

307.65

1.3

1.2

291.71

303.84

titre

0.05

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

880

1176

8.45

307.65

1.8

1.4

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

324

125

27.17

307.65

1.1

—

(3003396) Base excess in Arterial blood by calculation

2051

8598

2.99

307.65

9.7

7.4

1.34

0.94

mmol/l

4.08

1765

7019

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

889

1146

8.78

307.65

1.3

1.2

16.83

2.09

u/ml

2.13

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

704

1172

6.59

307.65

1.3

192.50

121.67

titre

0.27

(3013115) Eosinophils [#/volume] in Blood

5353

31275

4.40

307.65

13.7

6.2

0.21

0.20

e9/l

3.30

4931

26754

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

381

388

10.35

307.65

2.0

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1067

1167

10.67

307.65

2.0

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

402

430

9.88

307.65

2.0

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1315

1210

13.25

307.65

1.3

1.2

50.66

0.60

u/ml

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1141

1829

7.30

307.65

1.3

1.2

1.91

0.97

u/ml

0.90

159

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2366

9247

3.40

307.65

2.6

1.9

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

815

963

9.48

307.65

1.8

1.4

—

(3001604) Monocytes [#/volume] in Blood

5296

30297

4.44

307.65

13.0

6.0

0.67

0.62

e9/l

25.72

4816

25503

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1732

2572

8.71

307.65

1.7

1.6

16.48

16.82

iu/ml

0.02

(3005719) IgG [Mass/volume] in Serum or Plasma

1668

4348

4.76

307.65

4.4

2.7

10.42

10.59

g/l

0.71

1605

3989

(3022096) Basophils/Leukocytes in Blood

4987

28074

3.95

307.65

13.8

6.3

0.64

0.65

1.52

4911

26076

(3005322) IgE [Units/volume] in Serum or Plasma

1137

3064

4.26

307.65

1.6

1.3

247.03

258.09

u/ml

0.13

1068

2809

(3037522) Nuclear Ab [Titer] in Serum

2933

7025

6.60

307.65

1.6

1.3

565.24

495.07

titre

1.20

885

1518

(3019977) pH of Arterial blood

2058

8645

2.98

307.65

9.7

7.4

7.43

7.42

6.90

1298

4765

(3023420) DNA double strand Ab [Units/volume] in Serum

1283

2017

7.61

307.65

2.1

1.6

7.38

6.83

iu/ml

0.24

292

490

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2563

8616

4.18

307.65

1.4

1.3

26.00

12.10

u/ml

3.54

760

3128

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

927

1345

7.83

307.65

1.4

1.3

11.94

5.25

u/ml

1.82

177

207

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

643

836

8.39

307.65

1.2

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

536

554

10.42

307.65

1.2

1.1

68.57

40.21

u/ml

0.88

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

801

1556

5.70

307.65

1.9

1.5

0.23

0.24

g/l

3.15

775

1481

(3013650) Neutrophils [#/volume] in Blood by Automated count

5344

34116

3.69

307.65

16.8

9.4

4.68

4.31

e9/l

24.70

4902

29255

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

736

814

10.02

307.65

2.5

1.4

—

(3042631) Mycobacterium sp identified in Specimen

723

925

8.63

307.65

3.0

2.7

—

(3023419) Bacteria identified in Sputum by Culture

790

825

10.71

307.65

2.8

2.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

507

697

7.78

307.65

3.5

3.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

723

967

8.25

307.65

1.5

1.3

16.16

10.31

u/ml

0.59

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2701

9290

4.17

307.65

1.4

1.3

58.13

34.52

iu/ml

6.11

926

2732

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

685

234

32.46

307.65

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

2077

8670

3.01

307.65

9.7

7.4

10.37

12.11

kpa

58.90

2012

8321

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1358

2201

7.47

307.65

1.3

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1167

1602

8.59

307.65

2.3

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

842

1699

5.52

307.65

2.6

2.3

128.39

127.50

g/l

0.31

406

1361

(3002030) Lymphocytes/Leukocytes in Blood

5011

28528

3.91

307.65

13.8

6.3

24.61

26.10

18.04

4940

26821

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1051

2388

5.03

307.65

1.9

38.87

38.63

u/l

0.12

967

2058

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2835

12312

3.24

307.65

2.9

1.9

—

(3006504) Eosinophils/Leukocytes in Blood

5001

28064

3.99

307.65

13.7

6.2

2.72

2.85

4.27

4923

26076

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

686

1470

5.08

302.38

1.9

2.0

11.64

12.72

mg/l

1.35

647

1356

(3017181) Myelocytes/Leukocytes in Blood

1526

5780

3.12

297.49

6.9

4.2

0.84

1.00

1.62

643

1869

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

406

533

8.04

292.10

2.1

1.5

—

(3002179) Metamyelocytes/Leukocytes in Blood

1460

5484

3.12

287.90

6.6

4.0

0.59

0.75

2.02

603

1750

(3004616) Nuclear Ab [Presence] in Serum

439

650

7.15

283.88

1.4

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1616

6521

2.94

279.69

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

367

474

8.13

267.47

1.3

1.2

78.08

78.95

u/ml

0.01

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3731

22846

2.41

267.23

4.4

3.4

1700.43

1740.40

ng/l

0.19

3396

20035

(3021440) Promyelocytes/Leukocytes in Blood

1428

5519

3.01

265.91

7.0

4.2

0.08

0.12

2.37

540

1615

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4847

33442

2.58

265.07

10.7

6.7

11.31

12.53

umol/l

8.44

4740

31899

(3027135) IgG subclass 1 [Mass/volume] in Serum

379

519

7.68

262.64

1.4

1.3

7.47

6.64

g/l

2.22

263

373

(3025159) Blasts/Leukocytes in Blood

1421

5515

3.00

262.31

7.1

4.4

0.24

0.23

0.02

525

1518

(3028192) IgG subclass 2 [Mass/volume] in Serum

378

519

7.65

261.33

1.4

1.3

2.97

2.89

g/l

0.30

266

376

(3024139) IgG subclass 3 [Mass/volume] in Serum

378

519

7.65

261.33

1.4

1.3

0.49

0.41

g/l

2.37

262

375

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

165

34.49

260.69

2.9

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

500

922

5.78

259.83

5.3

2.3

598.33

2207.70

u/ml

1.10

(4062490) Immunoglobulin typing, IgG

370

512

7.59

253.98

1.4

1.3

—

(3016502) Oxygen saturation in Arterial blood

1755

7838

2.67

246.43

10.4

7.6

93.82

95.42

18.40

1702

7563

(3024980) IgG subclass 4 [Mass/volume] in Serum

477

884

5.73

246.35

1.7

1.6

0.88

0.85

g/l

0.18

346

692

(3042936) Bacteria identified in Isolate by Culture

1970

9463

2.53

236.50

2.6

2.0

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4428

30155

2.35

235.33

10.6

6.9

1.20

1.21

mmol/l

4.46

4240

27750

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1185

4412

3.04

233.35

11.5

9.2

24.67

24.23

mmol/l

4.19

1152

4305

(3018418) pH of Serum or Plasma

3319

20209

2.26

228.76

6.1

4.4

7.40

2.40

2511

14676

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

288

337

8.88

227.21

4.1

3.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

317

426

7.76

222.99

1.3

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

373

600

6.52

222.36

2.0

1.6

—

(3021589) Normoblasts [#/volume] in Blood

3935

25920

2.24

220.39

23.3

12.5

0.00

e9/l

0.80

3340

20973

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

381

637

6.28

218.58

2.0

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2272

12024

2.34

216.43

9.9

4.8

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

5592

43092

2.71

213.39

10.6

4.5

18.23

13.81

mm/h

66.55

5484

39841

(3038026) Centromere Ab [Units/volume] in Serum

300

409

7.63

208.29

1.3

1.2

49.88

63.67

u/ml

0.27

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4683

33637

2.27

204.60

11.8

7.6

1.21

mmol/l

3.11

4085

28981

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

217

200

11.18

203.68

2.0

1.8

43367.15

18828.19

u/ml

0.25

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

917

3175

3.18

203.02

2.4

1.9

1.98

2.41

ug/l

0.34

834

2788

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

284

377

7.82

201.76

1.3

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1203

4884

2.78

199.66

6.0

3.9

5.15

5.14

kpa

0.04

1165

4642

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1282

5395

2.70

198.24

2.2

2.4

343.14

384.80

nmol/l

8.15

1223

4971

(3009343) pH of Capillary blood

1178

4751

2.79

197.87

6.0

3.9

7.42

7.34

1025

3936

(3007164) IgA [Mass/volume] in Serum or Plasma

1968

10178

2.32

194.22

2.0

1.5

2.80

2.62

g/l

2.59

1441

5891

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

595

1639

3.88

187.32

1.6

1.5

50.12

4.78

iu/ml

0.91

124

341

(1616796) Gas panel - Central venous blood

580

1591

3.89

183.60

5.4

3.9

—

(3011412) CD3 cells [#/volume] in Blood

311

506

6.39

183.01

2.2

2.1

1020.61

1103.30

e6/l

0.81

282

448

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1048

4160

2.80

180.31

5.6

3.7

2.29

1.84

mmol/l

3.45

833

3045

(40759836) Histone Ab [Presence] in Serum by Immunoblot

263

370

7.35

177.41

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

256

356

7.43

174.47

1.3

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

250

339

7.62

174.21

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

252

346

7.53

173.68

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

258

364

7.33

173.57

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

258

364

7.33

173.57

1.3

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2254

12789

2.14

173.35

2.4

1.7

1.54

1.47

mg/l

0.28

1887

10070

(3021879) Hepatitis B virus core Ab [Presence] in Serum

895

3351

2.93

171.23

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

766

2633

3.15

170.34

4.6

3.0

25.29

24.77

mmol/l

2.87

746

2592

(3021901) Oxygen saturation in Capillary blood

557

1571

3.77

169.07

4.6

3.0

88.68

89.12

0.73

544

1530

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1490

7212

2.37

168.31

11.8

8.1

123.29

120.11

g/l

6.70

1462

7052

(1175426) CD3 cells/Lymphocytes in Blood

265

399

6.87

167.92

2.1

2.0

72.68

70.92

0.76

255

373

(3017143) Hepatitis C virus Ab [Presence] in Serum

1164

5050

2.58

166.84

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

421

986

4.49

164.49

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

608

1857

3.50

163.59

5.4

3.3

7.70

7.97

kpa

3.99

593

1816

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

256

383

6.91

163.16

2.2

2.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

252

375

6.94

161.41

2.1

2.0

16.09

16.67

0.27

246

362

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

416

981

4.45

161.07

1.4

39.23

17.34

u/ml

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1271

5868

2.44

158.76

1.6

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

527

1498

3.73

157.91

3.7

2.7

15.80

16.06

1.01

516

1470

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

381

853

4.67

157.40

1.4

151.61

154.89

au/ml

0.17

102

255

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

295

532

5.75

156.06

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

295

532

5.75

156.06

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

295

532

5.75

156.06

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5671

46299

2.39

151.25

16.4

8.5

79.66

81.88

u/l

2.70

5576

43787

(36304419) Bacteria [Presence] in Urine

2809

17951

1.97

150.44

4.9

3.5

0.61

146.37

estimate

—

105

(21494815) CD4 cells/Lymphocytes in Specimen

260

430

6.25

150.34

2.2

39.26

37.89

0.56

255

422

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

190

221

8.82

150.30

1.2

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

4107

29832

1.96

149.84

6.9

5.2

33.60

34.84

g/l

35.29

3881

27818

(3032080) INR in Blood by Coagulation assay

4341

32281

1.96

145.87

19.4

19.1

1.31

1.34

inr

3.01

3757

27270

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2919

19096

1.93

144.03

5.3

3.2

34.61

36.50

u/l

0.55

2799

17887

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

278

512

5.62

143.72

1.4

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1053

4654

2.50

143.52

12.7

7.9

25.00

24.78

mmol/l

0.95

1042

4621

(3042733) HLA Ab [Presence] in Serum

145

124

11.93

142.78

4.3

4.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1981

11421

2.04

140.37

6.6

3.2

0.81

mmol/l

1.76

1871

10694

(3030467) Casts [#/volume] in Urine by Automated count

2893

19144

1.89

135.37

5.0

3.6

0.40

0.47

e6/l

0.91

2270

14409

(3018095) Leukocytes [#/volume] in Urine

3454

24214

1.87

134.51

6.4

4.3

110.72

112.42

e6/l

0.03

2658

17719

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

200

283

7.25

134.04

1.4

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

3206

22157

1.85

128.67

5.2

3.7

84.92

94.09

e6/l

0.09

2590

17248

(3026782) Osmolality of Urine

2175

13303

1.94

127.68

4.1

3.1

519.17

537.25

mosm/kgh2o

4.36

1991

11691

(3017732) Neutrophils [#/volume] in Blood

1403

7337

2.15

127.37

3.9

3.3

4.65

4.79

e9/l

0.36

1280

6118

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

3427

24231

1.84

127.22

5.3

3.7

—

1.75

—

(3010503) CD19 cells [#/volume] in Blood

210

336

6.42

125.37

2.3

2.2

100.73

114.16

e6/l

0.37

204

319

(3022948) Iron [Moles/volume] in Serum or Plasma

2034

12243

1.95

124.68

3.1

2.7

11.56

12.24

umol/l

4.52

1917

11337

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1009

4651

2.37

124.06

8.1

6.7

24.96

24.48

mmol/l

3.36

978

4458

(3001964) Herpes simplex virus Ag [Presence] in Specimen

139

142

9.97

121.22

2.9

1.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

4767

37630

1.90

121.21

9.3

5.3

6.83

6.85

mmol/l

0.44

4628

35938

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

268

557

4.97

120.81

1.4

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1828

10740

1.96

119.46

3.0

2.7

20.89

21.79

2.09

1721

9932

(3020779) Urea [Moles/volume] in Serum or Plasma

1313

6845

2.14

119.34

11.3

6.9

10.80

11.07

mmol/l

0.62

1263

6517

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1926

11537

1.94

118.73

3.0

2.7

2.23

2.26

g/l

1.07

1798

10602

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

167

221

7.72

118.69

3.6

1.8

42.98

60.93

ug/l

2.47

167

213

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1563

8730

2.03

117.83

4.9

4.3

263.37

246.65

u/l

3.60

1498

8254

(3020630) Protein [Mass/volume] in Serum or Plasma

1264

6542

2.15

116.81

2.4

2.6

66.13

65.91

g/l

0.42

1189

5925

(3024932) HLA-DR beta [Type]

126

118

10.86

116.79

1.0

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

2419

15667

1.85

116.50

3.9

2.9

4.65

4.56

e6/l

0.11

2253

14284

(3033099) Centromere Ab [Titer] in Serum

120

105

11.62

116.37

1.2

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

514

1740

3.11

115.93

3.4

2.3

3.81

3.63

g/l

1.89

502

1651

(3024471) HLA-A [Type]

127

122

10.59

115.67

1.0

—

(3027315) Oxygen [Partial pressure] in Blood

456

1443

3.32

115.06

6.6

4.4

8.25

8.46

kpa

1.66

447

1409

(3012501) Base excess in Blood by calculation

450

1435

3.29

112.08

6.6

4.3

2.70

2.64

mmol/l

0.18

345

969

(3010421) pH of Blood

592

2209

2.84

112.06

5.9

3.9

7.42

7.41

2.51

583

2179

(3013290) Carbon dioxide [Partial pressure] in Blood

450

1436

3.29

111.95

6.6

4.3

5.01

4.98

kpa

0.25

441

1403

(21494814) CD8 cells/Lymphocytes in Specimen

160

216

7.56

111.75

2.1

30.94

31.68

0.18

160

216

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

203

354

5.88

111.06

1.5

1.3

1.16

2.19

u/ml

0.91

132

208

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

17.39

111.00

1.6

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

147

184

8.14

109.50

2.1

2.0

1.86

1.69

ratio

0.39

138

173

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

291

701

4.29

109.17

1.3

1.2

5.85

3.45

u/ml

0.57

134

227

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1184

6123

2.13

108.94

4.3

3.2

224.28

237.27

ng/l

0.46

1116

5654

(40758558) Short blood count panel - Blood

2680

18221

1.78

107.61

10.3

6.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

545

1997

2.88

106.56

1.7

—

(3017569) Oxygen content in Arterial blood

224

448

5.14

105.51

2.4

2.1

16.44

15.96

1.14

224

448

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2970

20948

1.74

103.75

3.6

2.2

149.13

225.73

u/l

7.73

2828

19710

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

969

4729

2.22

102.77

2.1

1.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

5002

40957

1.85

102.68

7.3

5.0

1.68

2.17

—

(40757373) Influenza virus identified in Isolate

116

118

9.98

101.44

2.8

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1028

5166

2.17

101.22

1.9

1.7

—

(3010375) cycloSPORINE [Mass/volume] in Blood

153

220

7.09

101.00

45.5

25.4

153.81

105.05

ug/l

8.82

121

180

(3014576) Chloride [Moles/volume] in Serum or Plasma

1684

10097

1.89

100.82

12.0

7.0

103.83

104.35

mmol/l

4.24

1684

10092

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

311

840

3.83

99.69

1.2

342.12

282.90

u/ml

1.52

198

502

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1581

9328

1.91

99.25

8.2

6.0

1.05

1.04

mmol/l

0.60

1486

8643

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

187

336

5.70

99.11

2.1

2.2

469.20

514.45

e6/l

0.44

144

274

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

888

4248

2.26

98.63

14.9

9.6

16.02

15.88

0.75

858

4107

(3015377) Calcium [Moles/volume] in Serum or Plasma

3110

22434

1.71

98.47

4.4

3.6

2.34

2.35

mmol/l

3.06

2896

20155

(3028271) Lactate [Moles/volume] in Capillary blood

361

1091

3.44

97.78

2.3

1.9

1.64

1.71

mmol/l

0.67

355

1060

(3000991) Gas panel - Venous blood

1183

6346

2.05

97.72

13.5

8.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

468

1656

2.96

97.31

3.6

2.2

90.24

89.43

0.34

457

1596

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

184

333

5.65

96.77

2.3

216.39

237.27

e6/l

0.49

159

290

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

273

689

4.09

96.17

1.3

1.2

5.28

4.41

u/ml

0.27

167

303

(3026493) Urate [Moles/volume] in Serum or Plasma

2477

16867

1.74

96.00

4.9

3.0

360.29

358.93

umol/l

0.25

2221

14593

(3014111) Lactate [Moles/volume] in Serum or Plasma

1212

6602

2.02

95.76

12.0

7.4

1.43

1.36

mmol/l

1.17

1183

6467

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

207

421

5.04

95.61

2.3

2.4

37.14

26.19

iu/ml

0.39

(3009871) Measles virus Ab [Titer] in Serum

119

138

8.76

94.27

1.4

1.7

2120.00

3803.33

titre

1.14

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

175

311

5.75

93.83

1.7

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

175

311

5.75

93.83

1.7

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

175

311

5.75

93.83

1.7

1.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

436

1527

2.98

92.24

3.8

2.4

211.47

208.02

0.31

418

1456

(3021601) Nitrite [Presence] in Urine by Test strip

4035

31533

1.69

92.15

5.5

4.2

0.00

estimate

1.34

1179

6725

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

253

624

4.17

91.91

1.3

1.1

118.49

114.08

1.13

243

551

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

173

311

5.68

91.63

1.7

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

147

225

6.66

91.54

1.7

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

147

225

6.66

91.54

1.7

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

147

226

6.63

91.15

1.7

2.0

—

(3026250) Tacrolimus [Mass/volume] in Blood

136

194

7.13

90.42

48.0

36.6

8.00

7.22

ug/l

2.74

123

173

(4195642) Thrombophilia screening test

250

619

4.16

90.34

1.3

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

4063

31919

1.68

89.90

5.5

4.2

4.84

4.75

estimate

0.01

1202

6950

(3009261) Glucose [Presence] in Urine by Test strip

4080

32119

1.68

89.26

5.6

4.3

0.01

0.22

estimate

0.71

1129

6447

(3048929) Epstein Barr virus Ab [Presence] in Serum

370

1205

3.19

88.69

1.3

1.2

—

(3022313) Gas panel - Capillary blood

726

3331

2.32

88.54

6.4

4.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3534

26899

1.66

87.26

3.2

2.4

77.83

79.09

nmol/l

1.93

3283

23801

(3027945) Reticulocytes/Erythrocytes in Blood

1514

9142

1.85

86.79

3.5

2.5

1.93

1.77

6.78

1359

8103

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2028

13413

1.73

84.92

5.4

4.3

419.72

481.19

ng/l

0.29

1812

11482

(4268621) Lupus anticoagulant assay

209

476

4.50

84.17

2.4

2.3

—

(3033658) Prothrombin time (PT) actual/Normal

2313

15905

1.69

83.63

6.7

4.4

84.60

84.59

0.00

2273

15564

(3008536) Aspergillus sp Ab [Presence] in Serum

106

125

8.60

82.85

1.6

1.8

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

209

487

4.40

81.76

1.2

96.82

95.03

0.39

203

452

(3031040) Bacteria [#/volume] in Urine by Automated count

4829

40267

1.69

79.85

6.8

5.3

612.09

1998.50

e6/l

2.79

669

(3036489) Thrombin time

518

2138

2.54

79.55

3.4

2.0

21.40

0.00

478

1930

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1153

6549

1.92

79.22

2.4

2.2

0.21

0.20

g/l

1.82

1068

6089

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

244

653

3.84

79.14

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

122

179

6.92

79.04

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

10.75

78.46

1.2

43.62

43.34

mg/l

0.01

(40761536) Microorganisms panel - Urine sediment

901

4725

2.05

77.84

5.6

4.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

200

472

4.34

76.96

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1278

7567

1.85

76.92

5.1

3.8

5.86

5.80

kpa

1.05

1242

7376

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

161

318

5.16

76.89

1.2

88.69

81.25

0.81

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

165

334

5.04

76.61

2.0

1.5

5.96

6.49

u/l

0.36

150

283

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3623

28282

1.60

76.49

3.1

2.5

—

(3002032) Base excess in Venous blood by calculation

1249

7356

1.86

76.41

5.1

3.8

2.12

1.75

mmol/l

2.73

1099

6391

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

988

5423

1.96

74.80

5.1

4.2

1.22

mmol/l

3.30

901

4680

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

187

429

4.45

74.61

1.3

1.2

120.00

117.50

titre

0.03

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

187

429

4.45

74.61

1.3

1.2

160.71

144.48

titre

0.12

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2537

18257

1.62

74.55

2.7

2.4

3.04

2.91

mg/l

1.85

2259

15676

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

384

1412

2.82

74.07

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

384

1412

2.82

74.07

1.5

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

1221

7204

1.85

74.03

3.4

2.5

72.16

67.78

e9/l

3.21

846

5346

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1672

10847

1.72

73.14

2.9

2.0

29.90

29.98

0.22

1632

10537

(3012544) pH of Venous blood

1280

7690

1.82

73.07

5.1

3.8

7.38

1.06

748

4529

(3014007) Fractional oxyhemoglobin in Arterial blood

912

4912

1.99

72.79

14.9

9.3

92.53

93.89

8.99

906

4894

(3046861) Legionella sp Ag [Presence] in Urine

16.08

69.24

1.1

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

152

314

4.93

68.93

2.5

37.95

37.72

0.04

173

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3313

25717

1.56

68.61

5.6

4.4

92.10

82.14

ng/l

0.07

2731

20125

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

205

537

3.91

68.52

1.1

1.78

2.57

iu/ml

—

(4015189) Microbial culture of sputum

108

167

6.56

66.61

2.0

2.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

588

2776

2.22

66.24

2.8

3.4

71.35

79.70

mg/l

0.13

451

2389

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

587

2772

2.22

66.08

2.8

3.4

42.90

54.67

mg/l

1.10

448

2383

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

869

4760

1.95

65.61

15.4

9.4

0.60

0.63

1.41

860

4727

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3364

26377

1.55

65.36

3.8

3.2

193.19

153.84

ug/l

7.81

3123

24205

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

889

4916

1.93

65.23

15.1

9.2

1.33

1.30

0.60

880

4885

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

802

4282

1.99

65.20

5.0

3.8

24.34

24.10

mmol/l

1.30

796

4229

(3015736) pH of Urine

3260

25433

1.54

64.47

4.5

3.7

6.22

6.26

1.15

1610

13876

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1654

11024

1.66

64.01

4.6

3.4

1.80

1.97

e6/l

0.36

855

5679

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

8.79

63.78

1.1

1.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

712

3697

2.03

62.47

1.7

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1144

6946

1.78

61.99

4.9

3.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

151

339

4.53

61.92

2.4

2.2

0.57

0.64

e9/l

0.68

135

320

(4035726) Immunohistochemistry procedure

968

5598

1.85

61.59

1.5

1.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

107

178

6.09

61.43

2.0

1.9

30.72

29.58

0.26

101

165

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

9.81

60.69

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

531

2491

2.23

60.60

2.7

3.2

1.85

5.03

ratio

1.59

254

1491

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

5078

44060

1.61

59.89

43.2

23.9

14.31

13.86

84.27

5060

43449

(3034426) Prothrombin time (PT)

135

6.89

59.62

1.1

1.3

26.84

28.73

2.60

135

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

237

750

3.24

59.43

1.1

1.57

1.55

g/l

0.26

211

678

(3006245) CD3-CD19+ cells/cells in Blood

104

177

5.95

58.35

2.2

1.9

9.21

11.88

0.92

159

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

115

7.38

57.95

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

146

6.51

57.74

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

545

2641

2.16

57.27

3.8

2.9

0.32

0.34

iu/ml

0.79

307

1446

(3037756) Immunofixation for Serum or Plasma

401

1710

2.43

57.04

1.5

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

652

3404

2.01

56.08

5.8

4.9

1.72

1.57

4.28

625

3226

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

317

1233

2.65

54.67

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

540

2671

2.11

53.71

3.2

2.2

342.23

718.10

ug/l

2.69

514

2553

(3020891) Body temperature

650

3452

1.98

53.15

5.2

4.6

36.95

36.91

°c

2.49

641

3415

(3021788) Differential panel - Synovial fluid

311

1217

2.63

52.98

1.7

1.5

—

1.00

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1717

12027

1.57

52.42

4.3

3.3

0.94

1.12

e6/l

1.29

933

6700

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

687

3765

1.92

51.12

2.2

1.6

1.60

1.56

g/l

0.49

591

3233

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

486

2355

2.15

50.93

2.4

2.3

0.05

g/l

0.05

444

2114

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

337

1405

2.47

50.29

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

298

1172

2.61

50.24

1.1

3.95

0.00

104

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

469

2261

2.15

49.77

2.5

2.3

0.00

g/l

0.79

416

1974

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

10.26

48.39

1.1

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2152

16055

1.50

48.32

5.3

3.8

0.11

0.30

estimate

0.84

1010

5208

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2601

20200

1.47

47.51

3.1

2.7

65.60

64.60

u/l

0.07

2433

18671

(3004809) Band form neutrophils/Leukocytes in Blood

300

1220

2.53

47.18

4.1

3.7

1.62

1.61

0.02

280

1068

(3024354) Oxygen [Partial pressure] in Venous blood

1006

6325

1.69

46.96

3.9

3.2

4.47

kpa

0.01

973

6149

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1128

7327

1.65

46.41

3.1

2.7

10.11

9.43

umol/l

0.39

988

6465

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

539

2810

2.00

46.26

2.6

2.4

0.63

1.02

g/l

2.00

475

2397

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

507

2593

2.03

45.90

7.0

4.2

24.98

24.75

mmol/l

1.04

477

2349

(3007930) Methemoglobin/Hemoglobin.total in Blood

583

3142

1.94

45.41

6.3

5.1

0.85

0.87

0.58

556

2975

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

601

3273

1.92

45.37

2.4

2.3

3.90

3.73

g/l

1.70

568

2963

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

538

2824

1.98

45.26

2.4

2.3

10.49

10.22

g/l

0.69

502

2480

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

601

3280

1.91

45.07

2.4

2.3

4.13

4.18

g/l

1.00

571

2968

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

601

3280

1.91

45.07

2.4

2.3

7.83

7.42

g/l

6.74

570

2964

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

570

3057

1.94

45.03

2.4

3.10

2.91

g/l

4.60

539

2746

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

434

2111

2.13

44.93

2.6

2.4

0.00

g/l

-0.00

416

1968

(3039744) RNA polymerase III Ab [Units/volume] in Serum

12.30

44.40

1.0

1.1

5.50

1.80

u/ml

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

337

1491

2.33

43.99

1.8

1.6

—

(3047181) Lactate [Moles/volume] in Blood

432

2126

2.10

43.35

7.9

5.8

1.39

1.34

mmol/l

0.56

394

1893

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

262

1041

2.58

43.24

1.3

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

2349

18142

1.45

42.97

5.6

4.4

0.00

estimate

1.73

1077

6033

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1851

13664

1.49

42.66

3.0

3.2

2.48

2.46

mmol/l

8.23

1688

12199

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

103

237

4.40

41.02

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

1127

7524

1.60

40.97

2.1

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

333

1521

2.25

40.30

1.3

1.2

121.28

118.68

titre

0.04

121

(3024891) Influenza virus A+B Ag [Presence] in Specimen

293

1267

2.37

40.29

1.3

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5944

54974

1.67

40.20

38.6

19.4

26.31

27.47

mg/l

2.28

5666

46682

(40768797) Stomach Pathology biopsy report

1255

8632

1.56

39.99

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

103

242

4.31

39.94

1.2

1.06

1.07

ratio

0.19

187

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

178

605

2.99

39.56

1.1

3.24

3.31

0.02

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

381

1862

2.11

38.88

1.6

1.4

—

(3000012) Reticulocyte production index

274

1181

2.38

37.95

2.6

2.1

0.97

0.87

1.85

210

821

(3014051) Protein [Presence] in Urine by Test strip

2086

16107

1.43

36.81

4.3

3.2

0.03

0.07

0.75

521

(3026008) Bacteria identified in Urine by Culture

2563

20533

1.40

36.54

4.0

3.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

460

2473

1.92

35.89

4.5

3.9

1.39

1.40

mmol/l

0.11

453

2430

(3034770) Mitochondria Ab [Titer] in Serum

321

1518

2.17

35.64

1.2

908.46

985.78

titre

0.10

(3047007) Chlamydophila sp Ab [Presence] in Serum

171

606

2.87

35.28

1.2

—

(3018572) Chloride [Moles/volume] in Blood

314

1493

2.16

34.38

8.1

6.8

103.80

105.00

mmol/l

4.73

288

1339

(3039000) Anion gap in Blood by calculation

314

1493

2.16

34.38

8.1

6.8

11.63

11.30

mmol/l

1.00

288

1338

(3004451) EKG impression Narrative

135

428

3.20

33.83

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

367

1871

2.02

33.36

4.1

3.6

2.62

1.89

index

1.21

214

969

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

182

4.49

33.29

1.1

22.15

5.16

u/ml

0.58

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

200

4.29

32.95

1.4

2.1

198.95

173.14

1.25

190

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

35.21

32.74

1.0

14.73

14.19

mg/l

—

(3000060) B lymphocytes [#/volume] in Blood

116

5.47

32.62

2.2

1.9

0.84

1.51

e9/l

0.27

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

353

1794

2.02

32.37

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1546

11550

1.44

31.85

1.3

1.19

1.72

u/ml

1.91

391

2903

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

361

1878

1.97

30.98

3.4

2.9

1.81

1.74

mg/l

0.79

336

1662

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2824

23424

1.35

30.73

5.6

4.3

0.96

0.37

estimate

0.40

1042

5516

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

421

2313

1.87

30.67

1.4

1.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

156

572

2.77

30.24

1.7

1.8

4.29

4.57

mg/l

0.30

147

546

(3042111) Morphology [Interpretation] in Bone marrow Narrative

274

1301

2.15

30.11

1.7

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1916

14997

1.39

29.88

4.8

4.0

0.14

0.47

0.52

183

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

206

879

2.39

29.22

1.2

1.3

200.44

204.15

miu/ml

0.04

315

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

149

4.60

28.87

2.4

2.6

1.82

2.05

ratio

0.38

135

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4005

35188

1.34

28.74

4.7

3.4

65.59

55.00

u/l

5.99

3768

32397

(3008757) Leukocyte morphology finding [Identifier] in Blood

176

707

2.53

28.46

4.8

4.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

328

1705

1.97

28.20

1.8

1.6

13613.41

14730.82

e6/l

0.15

234

1188

(3021960) Folate [Moles/volume] in Serum or Plasma

2468

20252

1.34

28.05

1.9

1.8

19.29

19.98

nmol/l

1.49

2162

17071

(3045142) Bone marrow Pathology biopsy report

194

822

2.40

27.97

1.5

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

224

1019

2.24

27.39

1.8

1.9

4.24

4.63

mmol/24h

1.06

203

875

(3016650) Hepatitis A virus Ab [Presence] in Serum

194

833

2.37

27.15

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

110

5.13

27.04

1.5

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

159

625

2.58

26.91

1.7

1.4

13.75

13.15

u/l

0.48

153

600

(3036782) Glucose [Moles/volume] in Pleural fluid

194

839

2.35

26.72

1.5

1.4

6.61

6.33

mmol/l

0.58

179

780

(3004119) Hemoglobin [Mass/volume] in Venous blood

713

4699

1.58

26.59

4.7

3.3

126.37

127.84

g/l

0.98

691

4558

(3006571) Granulocytes/Leukocytes in Synovial fluid

182

770

2.40

26.34

1.7

1.5

58.16

61.40

0.51

111

507

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

128

4.72

26.33

1.1

1.2

91.35

82.68

1.10

(40768804) Tissue Pathology biopsy report

2788

23501

1.32

25.55

2.5

2.3

—

(3003129) Base excess in Capillary blood by calculation

197

875

2.29

25.52

3.4

2.3

0.87

0.35

mmol/l

1.13

190

841

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

5.88

25.20

1.7

1.5

92.81

96.30

au/ml

—

(3025941) Bacteria identified in Stool by Culture

468

2817

1.71

24.98

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

193

862

2.28

24.69

10.8

14.9

7.55

7.36

mmol/l

0.29

172

719

(3048689) Calprotectin [Mass/mass] in Stool

899

6333

1.48

24.50

2.5

2.2

187.73

158.04

ug/g

1.39

746

4991

(3003434) Protein [Mass/volume] in Pleural fluid

251

1249

2.05

24.41

1.5

32.87

31.35

g/l

1.06

218

1122

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

133

4.47

24.23

1.1

1.4

92.85

82.03

1.14

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

164

691

2.41

23.98

1.1

7.44

20.60

au/ml

2.12

123

(3003327) Ova and parasites identified in Stool by Light microscopy

310

1673

1.89

23.84

1.9

1.7

—

(3012441) Differential panel - Pleural fluid

203

940

2.20

23.80

1.6

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

191

863

2.25

23.78

1.4

1.3

457.21

370.31

u/l

0.67

179

818

(3019309) Folate [Moles/volume] in Red Blood Cells

1647

12967

1.36

23.72

1.9

1.8

1183.05

1152.92

nmol/l

0.58

1255

9751

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

159

667

2.42

23.49

1.3

14.66

13.05

u/l

0.41

143

613

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

171

3.95

23.40

1.0

1.1

98.25

92.58

0.97

124

(3003329) Lymphocytes/Leukocytes in Synovial fluid

145

586

2.51

23.22

1.9

1.4

37.01

27.70

2.12

375

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

210

1001

2.13

22.90

7.5

6.2

12.12

12.26

mg/l

0.18

195

928

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.03

22.75

1.2

1.4

10991.67

5340.00

u/ml

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

543

3478

1.61

22.73

4.5

3.5

25.58

25.11

mmol/l

2.05

516

3365

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

137

4.26

22.47

1.7

1.5

8.44

9.75

ug/l

1.45

137

(3044242) Glucose [Moles/volume] in Arterial blood

121

460

2.66

21.97

2.0

1.9

8.08

8.20

mmol/l

0.13

121

460

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

5.20

21.69

1.3

1.2

122.18

1069.37

ng/l

0.49

(40768806) Pleura Pathology biopsy report

195

923

2.15

21.67

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

848

6044

1.46

21.60

3.0

2.5

36.78

47.47

u/l

0.71

761

5097

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

214

1051

2.07

21.59

1.2

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

749

5225

1.49

21.26

1.7

1.67

1.56

2.95

634

4412

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

117

447

2.65

21.06

1.4

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

764

5366

1.48

20.95

4.7

4.0

101.01

97.08

ng/l

0.43

673

4541

(40768795) Lymph node Pathology biopsy report

146

624

2.37

20.74

1.5

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

112

4.49

20.73

2.3

2.0

7.17

9.32

mg/l

1.73

(3017354) Segmented neutrophils/Leukocytes in Blood

169

771

2.22

20.60

4.3

3.5

56.83

58.67

0.52

151

644

(3034891) Synovial lining cells/cells in Synovial fluid

293

3.03

20.45

1.7

1.4

4.00

3.74

0.07

(3026389) Candida sp identified in Specimen by Organism specific culture

165

755

2.22

19.98

1.5

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

446

2820

1.62

19.65

2.7

2.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

155

702

2.24

19.26

1.2

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3251

28602

1.26

19.21

3.7

2.9

—

estimate

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

579

3909

1.53

19.17

4.0

2.8

0.63

0.62

0.42

579

3891

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

148

661

2.27

19.02

1.2

67.00

65.85

u/l

0.07

132

577

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1732

14118

1.30

18.84

1.9

1.8

41122632.40

27428205.79

pmol/l

0.35

1408

11492

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

113

4.27

18.72

1.6

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

268

1503

1.82

18.29

2.7

2.4

32.55

33.66

umol/l

0.32

253

1334

(3045788) Cell count panel - Pleural fluid

177

864

2.08

18.21

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

143

3.80

17.99

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

265

1492

1.81

17.86

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

333

2005

1.70

17.74

1.4

1.5

284.02

262.01

ug/g

0.49

207

1231

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

359

2.67

17.54

1.6

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

359

2.67

17.54

1.6

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4583

42262

1.26

16.89

4.5

4.2

15.01

15.02

pmol/l

0.11

4198

38134

(40768443) Skin Pathology biopsy report

446

2923

1.56

16.87

1.2

—

(3045424) Erythrocytes [Presence] in Urine

479

3192

1.54

16.81

2.5

2.2

0.09

0.29

estimate

0.31

155

882

(21491868) Cryoglobulin [Mass/volume] in Serum

210

3.16

16.63

1.2

0.33

0.22

g/l

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

6.45

16.63

1.1

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

6.45

16.63

1.1

1.0

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

556

3834

1.49

16.59

5.0

4.2

44.28

46.69

1.45

549

3773

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

112

472

2.40

16.50

1.3

1.2

98.16

100.87

pmol/l

0.28

112

472

(3050794) Legionella sp Ab [Presence] in Serum

5.56

16.46

1.1

—

(40768446) Kidney Pathology biopsy report

203

3.17

16.22

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

318

2.69

16.04

4.2

3.3

1.08

1.38

0.88

318

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

174

888

1.98

15.89

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

306

1877

1.66

15.22

1.4

1.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

206

3.08

15.20

2.8

1.5

1.97

1.92

umol/l

0.21

186

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3327

29847

1.23

14.79

2.4

2.3

92.02

94.06

pmol/l

1.68

1873

16072

(3019550) Sodium [Moles/volume] in Serum or Plasma

5954

57060

1.36

14.72

40.5

23.8

139.06

139.63

mmol/l

48.59

5908

55944

(3019832) Treponema pallidum Ab [Presence] in Serum

349

2236

1.59

14.57

1.4

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

289

1768

1.66

14.54

3.3

0.87

0.82

nmol/l

0.98

231

1416

(3024928) Oxygen saturation in Venous blood

298

1843

1.65

14.37

4.2

3.0

63.13

60.28

1.35

291

1783

(3020682) Albumin/Creatinine [Ratio] in Urine

2618

22968

1.23

14.29

4.8

4.2

11.62

9.35

mg/mmol

1.35

1708

14591

(3023103) Potassium [Moles/volume] in Serum or Plasma

5955

57140

1.35

14.02

40.9

24.0

4.02

4.00

mmol/l

5.10

5901

55945

(3023199) Leukocytes [#/volume] in Pleural fluid

195

1079

1.83

13.98

1.5

4407.90

2978.64

e6/l

0.28

124

762

(3009508) Creatinine [Moles/volume] in Urine

2610

22940

1.22

13.87

3.9

3.5

7.03

7.34

mmol/l

3.68

2179

19068

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

393

2620

1.53

13.77

2.3

1.8

—

(3044927) Protein electrophoresis panel - Urine

153

792

1.95

13.47

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

108

491

2.22

13.43

1.1

1.31

1.01

u/ml

0.20

267

(3013727) Leukocytes other/Leukocytes in Blood

233

2.81

13.37

4.2

3.7

59.07

54.23

0.98

224

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

688

5131

1.38

13.29

3.7

2.8

55.16

61.55

ml/min/173m2

4.96

356

2229

(3035880) pH of Pleural fluid

105

474

2.23

13.28

1.3

7.38

7.40

0.59

322

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

135

674

2.02

13.18

1.1

1.15

1.78

u/ml

0.54

380

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.45

13.04

1.0

—

(3012516) Albumin [Mass/volume] in Urine

2543

22449

1.21

12.55

4.0

3.5

63.62

52.02

mg/l

1.62

1733

14723

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

381

2.33

12.31

1.1

1.2

112.30

93.21

u/l

0.49

317

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

451

2.21

12.29

1.3

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

108

3.63

12.28

1.2

—

580.00

—

(3017704) Immunofixation for Urine

426

2.25

12.25

1.3

1.5

—

(3022145) Colonoscopy Study observation

893

7015

1.31

12.16

1.4

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

185

1055

1.77

12.06

1.6

1.9

22.79

23.68

ug/l

0.08

180

1031

(3014133) Dog dander IgE Ab [Units/volume] in Serum

431

2.22

11.92

1.1

2.50

2.30

u/ml

0.07

226

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.82

11.88

1.0

1.3

89.08

76.45

0.58

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

370

2.31

11.77

1.1

1.3

50.08

25.08

u/l

1.14

304

(3028308) Erythrocytes [#/volume] in Pleural fluid

171

960

1.80

11.76

1.5

126960.94

53168.49

e6/l

1.25

545

(3044640) Blood type and Crossmatch panel - Blood

2347

20656

1.21

11.73

3.3

2.6

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

5519

52712

1.25

11.40

33.8

19.4

73.24

74.16

ml/min/173m2

2.64

5299

49337

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

4.58

11.16

1.3

1.7

—

(3019230) Fractional oxyhemoglobin in Venous blood

246

1548

1.61

11.13

4.6

2.6

63.12

61.47

0.56

246

1542

(3023430) Cat dander IgE Ab [Units/volume] in Serum

405

2.21

11.12

1.1

1.19

3.09

u/ml

1.46

186

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.71

11.09

1.1

1.2

75.82

80.43

0.26

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

357

2.28

10.93

1.2

1.1

31.30

28.39

u/l

0.17

312

(3003888) Timothy IgE Ab [Units/volume] in Serum

111

556

2.01

10.82

1.1

3.06

3.15

u/ml

0.03

283

(3051611) Lipemic interference index of Serum or Plasma

129

682

1.91

10.76

4.9

3.5

14.13

12.45

index

1.03

368

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

9.57

10.72

1.3

1.2

0.93

1.13

iu/ml

0.29

(3023383) Lactate [Moles/volume] in Pleural fluid

262

2.50

10.69

1.4

1.3

3.71

3.37

mmol/l

0.36

239

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

245

2.54

10.63

1.2

1.1

10.19

21.02

u/ml

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

362

2.25

10.59

1.2

1.1

88.96

84.10

u/l

0.20

319

(3006922) Hepatitis E virus Ab [Presence] in Serum

383

2.21

10.47

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

283

2.42

10.46

6.3

3.8

68.47

66.02

mg/l

0.09

196

(3001893) Eosinophils/Leukocytes in Pleural fluid

265

2.47

10.45

1.4

2.38

2.43

0.02

227

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

360

2.24

10.30

1.1

0.22

0.21

u/ml

0.05

147

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5932

57299

1.28

10.17

24.0

13.2

24.79

25.57

u/l

3.06

5875

55315

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

807

6401

1.30

10.15

1.5

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

126

675

1.88

10.12

2.8

3.3

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

9.11

9.99

1.6

1.3

2.08

0.64

mg/l

0.52

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

9.11

9.99

1.5

1.3

3.99

1.08

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

9.11

9.99

1.5

1.3

1.33

3.12

mg/l

0.60

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

9.11

9.99

1.6

1.3

4.75

2.11

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

9.11

9.99

1.6

1.3

1.93

1.18

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

9.11

9.99

1.5

1.3

0.71

0.88

mg/l

0.12

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

9.11

9.99

1.6

1.3

1.62

2.73

mg/l

0.29

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

9.11

9.99

1.5

1.3

2.19

2.15

mg/l

0.01

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

9.11

9.99

1.6

1.3

0.98

1.32

mg/l

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

156

2.90

9.93

1.7

1.6

0.32

0.39

ug/l

0.77

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.83

9.92

1.2

1.4

260878.65

121545.54

nmol/l

0.20

(44806071) Cardiolipin IgM antibody measurement

4.25

9.82

1.0

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

8.72

9.76

1.6

1.3

0.41

1.97

mg/l

—

(36660697) Celiac disease serology panel - Serum

546

4122

1.35

9.72

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

382

2.16

9.72

1.5

1.6

8.31

7.06

u/l

0.35

307

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

602

7744

0.76

9.56

9.9

8.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

112

3.23

9.55

2.6

3.4

6.92

8.19

mg/l

0.42

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

118

634

1.88

9.43

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

105

546

1.94

9.26

1.1

0.69

1.08

u/ml

0.44

248

(3005532) Lymphocytes/Leukocytes in Pleural fluid

320

2.23

9.15

1.4

1.5

64.69

68.38

0.32

267

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

187

2.63

9.07

1.1

14.30

2.01

u/ml

1.11

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

11.45

9.05

1.3

0.57

0.13

iu/ml

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

293

2010

1.48

9.03

1.7

1.6

0.38

0.32

mg/l

0.82

139

899

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

132

2.97

9.01

1.3

1.5

3.82

8.17

1.73

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

217

2.50

9.00

1.1

—

(44813793) Dust mix specific IgE antibody measurement

297

2.27

8.99

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

478

3589

1.36

8.83

2.5

—

(3016750) Collection duration of Urine

371

2.12

8.81

2.1

478.22

495.67

min

0.66

263

(3020961) Endomysium IgA Ab [Titer] in Serum

310

2166

1.45

8.71

1.1

289.29

175.63

titre

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

174

2.65

8.68

5.7

7.7

6.05

5.97

kpa

0.17

151

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5324

51025

1.20

8.62

5.8

5.3

2.07

2.02

mu/l

1.28

4925

46373

(3041918) Cholesterol [Moles/volume] in Pleural fluid

164

2.69

8.54

1.2

1.82

1.48

mmol/l

1.01

108

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

804

6510

1.27

8.53

2.7

2.4

10.96

7.11

ug/l

4.26

707

5649

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1797

15791

1.19

8.52

3.2

2.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

305

2.21

8.46

1.0

1.1

9.57

10.81

iu/ml

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

4.88

8.35

1.9

2.0

1.19

1.36

mg/l

0.32

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

109

595

1.85

8.34

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

419

3110

1.37

8.34

2.9

3.4

4.21

4.40

pmol/l

3.12

368

2739

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

489

1.94

8.33

1.6

1.4

—

(3003181) Sodium [Moles/volume] in Urine

210

1369

1.55

8.27

1.5

1.4

63.37

61.73

mmol/l

0.25

186

1109

(3012565) Volume of 24 hour Urine

303

2.19

8.18

2.0

2.3

1837.69

1838.45

0.00

256

(21494434) Karyotype in Bone marrow

117

661

1.78

8.02

1.4

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

339

2.11

7.98

1.7

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

339

2.11

7.98

1.7

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

497

1.90

7.96

1.6

1.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5982

58108

1.25

7.95

45.0

26.0

88.35

84.13

umol/l

9.70

5941

57296

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

8.44

7.79

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

323

2.12

7.76

1.4

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

918

7630

1.24

7.71

3.4

4.2

14.37

28.79

ug/l

1.68

774

6352

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.87

7.69

1.5

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.87

7.69

1.5

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.87

7.69

1.5

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

359

2635

1.38

7.67

1.1

0.88

1.21

u/ml

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

4.33

7.67

1.2

2037.00

2767.59

ng/l

0.35

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.43

7.65

1.2

0.04

0.56

u/ml

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5469

52700

1.20

7.57

7.9

7.3

40.87

40.29

mmol/mol

4.53

5129

48594

(40761539) Cells [Type] in Urine sediment by Light microscopy

153

2.62

7.43

1.3

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

284

2.16

7.34

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

137

2.71

7.32

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.60

7.28

1.7

1.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

3.09

7.26

2.2

2.8

130.38

110.68

au/ml

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

3.49

7.25

1.3

1.0

10.15

14.46

iu/ml

0.25

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

320

2.07

7.17

1.4

1.2

—

(3020491) Glucose [Moles/volume] in Blood

432

1.91

7.06

2.1

2.2

7.49

6.95

mmol/l

0.97

290

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

437

1.89

6.84

1.1

—

(3037121) Protein [Mass/volume] in Urine

317

2329

1.38

6.77

2.9

3.2

345.87

471.36

mg/l

0.75

164

1042

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.30

6.67

1.0

1.7

—

(3006576) Bicarbonate [Moles/volume] in Blood

225

2.23

6.58

5.6

7.0

24.68

24.76

mmol/l

0.04

202

(3038071) Oxygen [Partial pressure] in Mixed venous blood

151

2.53

6.58

5.4

7.7

5.71

5.38

kpa

0.40

151

(21494890) Protein electrophoresis panel - 24 hour Urine

131

815

1.62

6.39

1.8

2.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

8.14

6.32

1.8

1.3

—

(3047189) Immunofixation for 24 hour Urine

390

1.88

6.09

1.7

1.6

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

201

2.25

6.06

1.4

25.06

23.12

0.15

168

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

173

1166

1.50

5.95

1.1

18.28

7.90

eliau/ml

0.66

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

184

2.29

5.92

1.3

1.2

—

(3008295) Osmolality of Serum or Plasma

120

747

1.62

5.87

1.4

1.3

272.35

276.94

mosm/kgh2o

1.30

101

556

(3035320) C reactive protein [Mass/volume] in Body fluid

476

1.77

5.82

3.2

2.8

32.76

33.47

mg/l

0.06

361

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

155

2.39

5.77

1.3

1.2

—

(3004775) Volume in Urine collected for unspecified duration

540

1.71

5.65

2.2

589.05

652.45

0.87

341

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

126

803

1.58

5.61

1.7

1.4

—

(3024263) Appearance of Synovial fluid

345

1.89

5.56

2.0

1.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

214

1524

1.42

5.55

1.3

1.2

—

(3035941) MCH [Entitic mass]

5996

58583

1.21

5.55

51.6

29.2

30.53

30.46

1.94

5962

57802

(3024731) MCV [Entitic mean volume] in Red Blood Cells

5996

58583

1.21

5.55

51.7

29.3

92.64

91.71

39.70

5960

57801

(3014765) Yersinia sp identified in Stool by Organism specific culture

213

1516

1.42

5.55

1.3

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

106

650

1.64

5.53

1.7

1.3

95989.94

138207.69

e6/l

0.34

433

(3005988) Vibrio sp identified in Specimen by Organism specific culture

126

806

1.57

5.53

1.7

1.4

—

(3026361) Erythrocytes [#/volume] in Blood

5996

58586

1.21

5.53

51.8

29.3

4.34

4.41

e12/l

19.00

5900

56986

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

5996

58587

1.20

5.52

53.6

29.9

39.65

39.81

1.59

5960

57778

(3007461) Platelets [#/volume] in Blood

5995

58578

1.20

5.51

51.9

29.4

244.26

240.75

e9/l

3.57

5917

57207

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

2.85

5.50

1.4

69.58

73.17

0.21

(3010813) Leukocytes [#/volume] in Blood

5996

58592

1.20

5.49

51.9

29.4

7.77

6.89

e9/l

72.19

5905

56981

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

259

3470

0.74

5.47

2.2

2.1

3.73

3.45

ratio

0.51

215

2784

(3000963) Hemoglobin [Mass/volume] in Blood

5996

58595

1.20

5.47

52.3

29.6

131.05

133.34

g/l

24.99

5964

57840

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

415

1.79

5.34

1.0

297.54

286.30

mg/l

0.66

373

(3045414) Leukocytes [Presence] in Urine

747

6314

1.21

5.27

2.6

2.2

0.01

estimate

0.19

184

1173

(3025468) Yersinia sp identified in Specimen by Organism specific culture

124

802

1.56

5.21

1.7

1.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

120

2.51

5.19

1.3

243.10

313.28

u/l

0.09

(3002523) Influenza virus A Ag [Presence] in Specimen

593

1.64

5.15

1.2

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

146

982

1.50

5.13

2.4

2.3

0.92

1.21

g/24h

1.02

574

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

209

1506

1.40

5.11

1.3

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

128

2.43

5.03

1.3

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

3.28

5.02

1.2

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

351

1.83

4.99

2.2

1.8

—

(3003694) ABO and Rh group [Type] in Blood

1702

15426

1.14

4.91

1.5

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

594

1.63

4.89

1.2

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

234

2.02

4.88

3.3

2.4

4.67

4.87

kpa

0.92

234

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

175

2446

0.71

4.85

2.0

1.8

3.31

3.39

mmol/l

0.39

131

1760

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

235

2.01

4.83

3.3

2.4

9.22

10.13

kpa

1.74

235

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

186

1328

1.41

4.81

1.2

1.3

40.66

38.06

u/l

0.08

167

1140

(3007919) Fasciola sp Ab [Titer] in Serum

9.01

4.78

1.3

1.1

—

(21494755) Public health laboratory ask at order entry panel

178

2473

0.71

4.77

1.3

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

251

1.96

4.71

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

704

5981

1.20

4.71

3.5

2.7

0.46

0.49

e6/l

0.10

682

5780

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

231

2.00

4.68

2.7

2.6

0.61

mmol/l

0.04

231

(3042010) Triglyceride [Moles/volume] in Pleural fluid

133

2.34

4.65

1.3

1.2

0.39

1.86

mmol/l

1.54

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.01

4.62

6.2

9.2

108.69

104.69

g/l

0.46

(44786800) Granulocytes/Leukocytes in Body fluid

104

2.51

4.53

1.2

1.3

18.14

22.85

0.24

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

284

1.87

4.48

1.3

83.84

436.68

ug/l

1.29

140

(3044416) Complement C4 [Mass/volume] in Pleural fluid

3.27

4.46

1.2

0.10

0.07

g/l

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

125

844

1.49

4.38

1.7

1.4

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

3.34

4.32

1.3

1.4

0.82

0.88

ml/s/173m2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

126

856

1.48

4.29

1.7

1.4

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

6.26

4.29

1.1

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

124

840

1.49

4.28

1.7

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.74

4.17

2.3

1.5

44.15

44.36

umol/l

0.01

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.24

4.13

1.5

1.6

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

4.01

4.09

1.5

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.86

4.05

1.0

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

244

1.89

4.05

4.6

1.6

211.30

105.09

umol/l

0.71

143

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.34

4.04

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.89

3.98

1.4

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

668

7733

0.85

3.90

5.2

5.4

32.48

33.15

0.82

481

4959

(3006969) Lambda light chains [Mass/volume] in Urine

4.79

3.86

1.0

0.25

0.12

g/l

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.53

3.79

1.0

14.95

7.90

u/ml

0.44

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

3.94

3.79

2.2

1.8

—

(3016135) IgD [Mass/volume] in Serum

8.76

3.77

1.3

1.4

184.86

40.90

mg/l

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.73

3.75

3.8

2.6

0.67

1.26

mg/l

2.60

(3001729) Color of Synovial fluid

2.79

3.68

2.4

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5482

53527

1.13

3.63

6.0

5.8

6.09

mmol/l

0.05

4989

48339

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.41

3.61

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

405

1.64

3.58

1.9

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

256

2015

1.28

3.56

1.4

1.3

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

242

1.82

3.51

1.5

1.4

24.38

19.11

0.52

222

(3008898) HLA-B27 [Presence]

174

1308

1.34

3.40

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.39

3.38

1.2

24.00

19.90

u/l

0.34

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

6.37

3.18

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

6.37

3.18

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

904

0.63

3.13

1.1

1.2

0.62

0.63

ratio

0.04

152

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

541

1.50

3.10

2.0

1.9

3970.43

3677.45

u/l

0.03

207

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

598

1.48

3.10

1.2

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

290

1.69

3.09

2.3

1.4

20.54

21.63

umol/l

0.09

266

(3020191) Ethanol [Moles/volume] in Serum or Plasma

441

1.55

2.99

1.4

1.3

1.09

1.12

promille

0.07

349

(3036670) Protein [Mass/volume] in Synovial fluid

226

1.77

2.97

1.3

1.2

33.26

40.10

g/l

2.22

107

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.28

2.93

1.4

1.9

108.43

39.31

pmol/l

0.58

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

121

2.07

2.92

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.71

2.91

1.3

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.83

2.91

1.2

1.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.32

2.90

1.5

1.3

102.38

113.65

ug/l

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

228

1.76

2.90

1.1

1426.49

1603.11

miu/ml

0.41

228

(3049717) Cytology report of Urine Cyto stain

378

3183

1.20

2.88

2.9

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.59

2.87

1.5

1.7

—

(40765096) Chromosome analysis panel by Banding

229

1.75

2.86

1.2

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

430

3666

1.18

2.85

2.4

2.5

33.02

22.67

au/ml

0.86

286

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

396

3352

1.19

2.85

1.3

58.16

58.53

au/ml

0.01

229

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.64

2.79

1.2

—

mmol/l

—

(40768441) Liver Pathology biopsy report

417

1.54

2.78

1.5

1.3

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

3.92

2.77

1.1

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.08

2.76

1.0

—

(40758292) HTLV I+II Ab panel - Serum

2.17

2.76

1.3

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

138

1.96

2.74

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

118

2.04

2.71

1.5

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

160

1.88

2.70

1.5

0.40

0.34

mmol/l

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.45

2.69

1.1

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

593

1.44

2.67

1.5

1.7

13.55

27.11

u/ml

2.60

119

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

344

2897

1.20

2.64

1.2

130.83

131.46

u/ml

0.01

104

1012

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

578

1.44

2.63

1.7

2.0

1.35

1.30

u/field

0.04

309

(3016038) Potassium [Moles/volume] in Urine

498

1.47

2.58

1.3

1.1

34.30

34.56

mmol/l

0.04

427

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

100

2.10

2.58

10.6

13.8

5.49

5.03

mmol/l

0.54

100

(3019150) Specific gravity of Urine by Refractometry

1521

14149

1.10

2.57

5.4

4.6

1.02

1.12

kg/l

0.50

1128

9730

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

107

2.06

2.56

1.1

1233.33

913.79

titre

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

147

1130

1.31

2.55

1.4

33.95

29.32

iu/l

0.80

114

961

(40757494) Bilirubin.total [Moles/volume] in Blood

363

1.55

2.52

2.4

2.5

23.36

35.21

umol/l

—

(3002256) Pathology report gross observation

935

8501

1.12

2.48

1.4

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.38

2.47

2.7

4.9

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

158

1.84

2.47

1.2

1.3

0.34

0.30

g/l

1.45

123

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1007

0.69

2.46

1.2

1.53

1.52

g/l

0.08

1007

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.38

2.46

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

343

1.55

2.42

1.5

1.3

1.21

1.19

nmol/l

0.06

243

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

117

1.97

2.39

4.8

7.5

11.00

10.17

1.13

117

(3020650) Glucose [Presence] in Urine

182

1.76

2.38

1.9

1.8

0.00

0.05

estimate

1.08

182

(3034274) Bile acid [Moles/volume] in Serum --fasting

297

1.59

2.38

1.1

1.6

6.39

10.88

umol/l

1.19

208

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

6.25

2.37

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

329

1.55

2.37

1.6

1.8

1.73

2.88

u/field

0.69

222

(3001186) Copper [Moles/volume] in Serum or Plasma

139

1.87

2.35

1.6

1.2

16.92

15.92

umol/l

0.46

124

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.82

2.34

1.1

—

(3048879) Bone marrow aspiration report

207

1.69

2.29

2.1

1.7

—

2.00

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

116

879

1.33

2.27

3.0

2.1

29.32

24.71

mg/l

0.41

301

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.48

2.26

1.3

1.6

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.56

2.21

1.2

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

2.86

2.20

1.4

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

336

1.52

2.18

3.2

3.0

227.49

206.35

u/l

0.97

329

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

237

1971

1.21

2.14

1.6

38.50

24.04

u/ml

0.45

361

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.30

2.14

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

193

1574

1.23

2.12

3.2

3.3

208.93

837.99

u/ml

1.80

172

1436

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

244

1.60

2.09

1.3

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

153

1.77

2.07

1.1

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

168

1.73

2.07

1.1

1.2

19.00

28.70

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

168

1.73

2.07

1.3

36.96

36.11

0.04

114

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

515

1.40

2.05

1.0

1.1

14.09

3.13

eliau/ml

0.76

172

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

4.00

2.04

1.0

1.1

0.01

0.04

u/ml

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

135

1062

1.28

2.03

1.4

10.51

10.21

u/l

0.10

108

845

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

839

0.70

2.01

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.08

2.01

2.1

5.6

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

133

1.81

1.99

1.2

0.82

77.26

mg/l

0.80

(3038177) Helicobacter pylori Ab [Presence] in Serum

724

1.33

1.98

1.2

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

726

1.33

1.95

1.4

1.3

0.19

0.21

nmol/l

0.40

597

(3041184) Isoniazid [Presence] in Urine

4.55

1.94

2.6

1.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

219

1.60

1.90

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

159

1.70

1.84

2.1

1.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

221

1.59

1.84

1.3

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5183

50920

1.08

1.82

4.8

4.6

1.33

1.27

mmol/l

8.88

4641

45826

(3020356) Listeria sp identified in Specimen by Organism specific culture

4.17

1.82

1.0

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

103

796

1.30

1.81

1.2

1.3

302.54

284.61

pmol/l

0.21

654

(4027681) Cerebrospinal fluid IgG ratio and IgG index

246

1.55

1.80

1.3

1.2

0.57

0.53

ratio

0.20

147

(3016018) Differential panel - Cerebral spinal fluid

632

1.33

1.79

1.2

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

113

1427

0.79

1.75

1.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

998

0.75

1.74

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

140

1.72

1.71

1.9

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

299

1.47

1.69

1.3

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.95

1.69

1.9

1.2

22.65

20.51

mmol/l

0.79

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

268

1.50

1.65

1.2

60.67

64.32

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

123

990

1.25

1.60

1.3

1.8

298.38

294.49

mu/l

0.05

109

914

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

515

1.34

1.59

1.4

124.00

329.02

titre

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.33

1.58

1.0

1.1

99.20

93.77

titre

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5537

54617

1.08

1.55

6.4

2.45

2.54

mmol/l

11.92

5038

49987

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.27

1.55

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

107

1.78

1.54

1.3

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

307

1.44

1.51

2.0

1.7

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

2.86

1.50

2.3

2.30

3.01

mg/l

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

103

820

1.26

1.49

3.4

3.8

25.98

34.96

u/ml

0.98

795

(3044007) Cell count panel - Peritoneal fluid

218

1.52

1.48

1.5

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

786

1.26

1.47

1.5

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.73

1.43

2.8

2.0

4.33

4.46

mmol/l

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.31

1.42

1.3

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2059

21420

0.94

1.40

4.5

5.0

22.07

22.31

0.26

971

11576

(3036525) Urea [Moles/time] in 24 hour Urine

2.25

1.40

3.8

3.3

—

(40768793) Breast Pathology biopsy report

139

1154

1.21

1.39

1.5

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

505

0.69

1.39

1.1

1.0

370.17

321.58

ng/l

0.37

340

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

2.08

1.38

2.7

1.5

63.33

62.17

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

167

1.56

1.34

2.3

2.4

4.09

253.45

ug/l

0.82

167

(3050129) First trimester maternal screen panel - Serum or Plasma

272

0.59

1.33

1.3

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.97

1.32

1.3

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

193

1.50

1.29

2.2

1.8

—

(3028707) Methadone [Presence] in Urine by Screen method

335

1.38

1.28

2.4

2.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

508

0.71

1.28

1.1

1.0

38.97

42.67

ng/l

0.18

337

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

102

829

1.23

1.28

1.4

1.3

9.10

2.79

nmol/l

0.33

796

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

506

0.71

1.26

1.1

1.0

822.17

701.05

ng/l

1.07

332

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

314

1.37

1.20

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

462

1.30

1.18

1.3

1.2

2.29

2.24

mmol/l

0.09

433

(3019174) dRVVT (LA screen)

2.11

1.18

1.4

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

206

1.46

1.17

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

127

0.47

1.16

1.5

1.6

55.10

51.80

ug/l

—

127

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

274

1.39

1.15

1.0

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

166

1.51

1.14

1.1

1.3

250.91

27.05

g/l

0.48

135

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

235

0.59

1.14

1.6

1.5

1.46

1.24

ratio

—

149

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

235

0.59

1.14

1.6

1.5

0.95

ratio

—

149

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

235

0.59

1.14

1.6

1.5

1.80

1.12

ratio

—

149

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

233

0.60

1.11

1.6

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

257

0.62

1.10

1.1

1298.80

283.41

ng/l

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.26

1.10

3.3

2.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

337

1.34

1.09

1.1

299.60

301.41

mg/l

0.02

293

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.82

1.08

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.82

1.08

1.7

2.6

0.50

0.36

u/field

0.23

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5410

53485

1.06

1.08

5.7

5.5

4.33

4.43

mmol/l

9.56

4925

49130

(1002224) Polysomnography panel

210

1849

1.14

1.08

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1005

0.81

1.08

2.0

1.9

—

(3011985) Renin [Units/volume] in Plasma

103

856

1.21

1.08

1.3

1.4

50.61

64.26

mu/l

0.41

755

(1761482) Bacteria [#/volume] in Urine by Culture

157

1815

0.86

1.08

5.4

4.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

270

1.37

1.06

6.2

5.1

53.20

55.63

u/ml

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

145

1.52

1.05

1.3

1.2

262.00

287.49

pmol/l

0.12

107

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

297

2678

1.11

1.05

3.2

3.4

9027.19

1426.28

u/ml

0.41

248

2316

(3025577) Chromium [Mass/volume] in Blood

454

1.28

1.04

1.9

2.1

1.63

2.20

ug/l

1.86

371

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

191

0.58

1.03

1.7

1.6

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.96

1.03

1.0

1.2

—

(3014891) Appearance of Pleural fluid

114

1.58

1.02

1.8

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

102

853

1.20

1.02

1.4

0.14

0.28

nmol/l

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5366

53067

1.05

1.01

5.6

5.4

1.39

1.43

mmol/l

6.92

4847

48373

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

166

1447

1.15

1.01

1.3

683.94

568.82

mg/l

0.31

154

1371

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

842

0.81

1.01

1.6

1.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

222

1.40

1.00

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

139

1.51

0.99

1.2

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

172

1.46

0.99

1.6

1.4

15.79

16.97

pmol/l

0.32

137

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

189

1.43

0.98

1.1

1.3

119.97

135.56

nmol/l

0.25

138

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.71

0.98

1.2

1.0

17.24

44.19

iu/ml

2.57

(40758358) Immune stain study

2.17

0.98

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.95

0.97

3.6

4.5

—

0.00

estimate

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.95

0.0

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

146

1268

1.15

0.95

1.2

3.86

3.84

mmol/l

0.06

136

1192

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.22

0.93

1.0

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.22

0.93

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

356

1.29

0.92

1.2

1.1

52.04

44.92

mg/l

0.46

298

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.07

0.89

1.0

1.3

—

(3027008) Opiates [Presence] in Urine

738

1.19

0.88

1.8

—

(3051101) Glucose [Moles/volume] in Cord blood

130

0.54

0.87

8.0

6.2

8.24

8.40

mmol/l

—

130

(3000330) Specific gravity of Urine by Test strip

328

3573

0.91

0.87

4.6

3.6

1.02

ratio

0.59

309

3241

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

186

1655

1.13

0.86

2.4

2.3

125.90

101.85

ug/min

0.41

113

953

(3028300) Cannabinoids [Presence] in Urine

741

1.19

0.85

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

568

1.22

0.85

2.0

1.8

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.78

0.84

1.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

819

1.17

0.81

1.1

64.85

280.12

iu/ml

0.51

157

(3043238) Trisomy 21 risk [Likelihood] in Fetus

201

0.65

0.81

1.5

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

141

1241

1.14

0.79

1.2

1.4

15.29

29.16

e6/l

0.70

920

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.78

0.0

1.2

—

260.15

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

142

1253

1.14

0.78

1.3

1.4

229.75

1075.86

e6/l

3.55

104

988

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

749

1.18

0.78

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

165

1.40

0.77

1.2

23.22

12.27

mm/h

1.57

165

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

350

1.26

0.75

2.3

2.1

66.00

188.29

ug/min

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

316

1.27

0.73

1.0

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

524

1.20

0.73

1.1

—

25.21

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.00

0.72

1.2

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.61

0.72

1.0

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

308

1.27

0.71

2.1

1.7

37.77

39.65

g/l

1.20

308

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.92

0.70

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

291

1.27

0.70

1.3

1.5

—

(3016879) Cocaine [Presence] in Urine

683

1.17

0.70

1.9

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

170

0.65

0.70

1.8

—

(3027944) Amphetamines [Presence] in Urine

730

1.17

0.69

1.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.53

0.68

1.0

1.1

—

(4212803) Bone marrow aspirate examination

1.60

0.68

1.2

1.1

—

(4034850) Laboratory test

199

1809

1.10

0.68

14.5

11.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

676

1.17

0.68

1.4

1.3

1.57

1.48

nmol/l

0.27

597

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

132

1173

1.13

0.67

1.8

1.6

1.07

0.83

nmol/l

2.44

107

979

(3047352) Trisomy 18 risk [Likelihood] in Fetus

192

0.68

0.67

1.5

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.79

0.66

1.4

1.5

1.46

3.49

nmol/l

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2710

26582

1.03

0.65

5.4

6.1

3.21

3.63

ug/l

0.29

2393

23848

(3005033) Fetal Nuchal fold Thickness US

190

0.68

0.65

1.5

1.27

—

132

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

310

2885

1.08

0.64

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

709

1.16

0.63

1.5

1.4

—

nmol/l

—

(3000764) Benzodiazepines [Presence] in Urine

737

1.16

0.63

1.9

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

129

1.40

0.63

1.5

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

181

1.33

0.63

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.52

0.62

1.0

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

488

1.19

0.62

1.0

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

199

1.31

0.62

1.3

1.2

10.10

11.95

pmol/l

—

(3023410) Appearance of Cerebral spinal fluid

535

1.18

0.61

1.3

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

254

2351

1.08

0.61

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

103

909

1.14

0.61

3.4

2.4

4.13

4.10

mmol/l

0.23

103

897

(3035285) Chloride [Moles/volume] in Venous blood

103

909

1.14

0.61

3.4

2.4

105.65

105.71

mmol/l

0.05

103

897

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

253

1.27

0.60

1.1

1.14

1.18

u/l

0.16

121

(3017446) Testosterone [Moles/volume] in Serum or Plasma

558

5310

1.06

0.59

2.7

2.3

12.39

12.68

nmol/l

0.39

488

4679

(3033705) Calcium.ionized [Moles/volume] in Venous blood

101

892

1.13

0.59

3.5

2.4

1.19

1.20

mmol/l

0.49

101

880

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.46

0.58

2.0

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

248

2302

1.08

0.57

1.6

1.8

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.48

0.57

2.1

3.0

37.66

89.44

pmol/l

2.33

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.45

0.55

1.9

1.7

—

(3025130) Human papilloma virus identified in Specimen

442

1.18

0.52

1.9

1.8

—

(3026726) Creatinine [Moles/volume] in Specimen

1.43

0.52

1.9

2.7

422.56

537.67

umol/l

—

(40768800) Prostate Pathology biopsy report

170

1849

0.92

0.51

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.50

0.51

2.3

2.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

278

1.22

0.51

1.0

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

144

1.32

0.50

1.4

1.3

56.29

72.17

mu/l

0.33

106

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.41

0.50

1.0

1.1

—

(3019225) pH of Specimen

686

6603

1.04

0.49

5.4

4.6

7.37

7.36

1.45

559

4742

(3020911) Cortisol [Moles/time] in 24 hour Urine

172

1.28

0.48

1.5

1.4

103.68

440.17

nmol/24h

1.16

172

(40762887) Creatinine [Moles/volume] in Blood

1.49

0.47

2.0

1.8

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

376

0.82

0.47

1.0

1.1

5.18

13.52

nmol/l

—

(4198724) Urine methamphetamine measurement

111

1.35

0.46

1.1

1.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.43

0.46

1.1

5.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2363

23246

1.03

0.45

2.1

2.0

1.39

1.32

mmol/l

4.36

1912

19152

(3009466) Valproate [Moles/volume] in Serum or Plasma

822

0.89

0.45

4.5

4.7

317.24

344.69

umol/l

0.86

708

(3023487) Leukocytes [#/volume] in Peritoneal fluid

257

1.21

0.43

1.5

2.1

522.19

3752.48

e6/l

0.56

181

(40765089) Chromosome analysis panel - Blood by G-banded

1.38

0.41

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.41

0.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.36

0.41

1.8

1.1

1.69

1.77

umol/24h

—

(44806420) Estimation of glomerular filtration rate

498

0.86

0.40

2.8

2.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

101

0.69

0.39

1.4

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.43

0.39

13.4

9.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.39

0.0

1.1

—

8.23

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

147

1366

1.08

0.38

1.8

10.87

8.64

iu/l

0.10

500

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.35

0.37

2.2

1.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

152

1.25

0.37

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

554

1.12

0.36

1.2

7.26

7.68

mmol/l

0.61

466

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

263

1.18

0.35

1.5

1.7

11.05

7.95

nmol/l

0.16

222

(3013139) Helicobacter pylori Ag [Presence] in Stool

372

3878

0.96

0.35

1.2

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

120

1112

1.08

0.34

1.4

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.37

0.34

1.0

1.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.36

0.34

3.3

4.6

55.55

39.47

mg/mmol

—

(3022621) pH of Urine by Test strip

508

4910

1.04

0.33

3.9

2.9

6.12

6.04

1.31

391

3490

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.30

0.33

1.0

1.1

0.02

0.03

u/ml

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

193

1.19

0.30

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1535

15599

0.98

0.30

3.2

3.5

0.72

0.82

ug/l

3.60

1112

11130

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

467

1.11

0.29

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

259

1.16

0.29

1.2

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

220

2096

1.05

0.29

1.6

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

148

1.22

0.29

1.4

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

139

1.22

0.29

2.2

2.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

139

1.22

0.29

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

150

1416

1.06

0.28

1.5

1.7

—

30.85

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.29

0.28

1.6

1.3

—

609.28

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.23

0.27

1.3

1.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

159

1.20

0.26

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

148

1405

1.05

0.24

2.1

1.7

23.40

4.67

mg/l

6.18

132

1071

(3011288) Drugs identified in Urine by Screen method Nominal

493

1.10

0.24

7.6

2.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

329

0.88

0.24

1.4

145.96

190.02

pmol/l

0.71

329

(3002079) Sodium [Moles/time] in 24 hour Urine

236

1.14

0.24

1.3

138.22

162.78

mmol/24h

1.03

236

(3006462) Nitrate [Presence] in Urine

293

1.13

0.24

4.9

3.8

—

(3022689) Creatine [Moles/volume] in Urine

201

0.85

0.23

1.5

1.4

6.93

7.34

mmol/l

0.20

201

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.28

0.23

1.4

1.1

6.34

6.19

mmol/l

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.77

0.22

1.0

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

116

1.21

0.22

1.4

1.1

0.85

0.69

umol/24h

—

(1761868) Lipid panel - Serum or Plasma

1739

17588

0.98

0.21

3.7

3.6

—

(4038314) Semen analysis, post vasectomy

0.00

0.21

0.0

1.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1316.00

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

313.10

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

1.38

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

135

1.19

0.21

1.1

1.09

0.51

u/ml

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.22

0.21

1.0

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

201

1.14

0.21

1.3

1.5

14.54

14.13

g/l

0.07

155

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.16

0.21

1.2

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

32.98

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

8.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

449

0.91

0.20

1.8

1.9

117.79

117.65

ng/l

0.00

449

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

386

0.91

0.20

1.2

1.4

28.97

30.57

u/l

0.12

318

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

271

0.89

0.20

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

165

0.85

0.19

1.9

2.5

1.32

1.23

ug/l

0.08

156

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

165

1.15

0.19

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

154

0.84

0.19

1.3

1.4

1.18

1.17

mmol/l

0.15

154

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

137

1.17

0.18

2.3

2.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.13

0.18

1.0

1.2

7.83

11.26

u/l

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

424

1.09

0.18

3.6

5.7

101.33

49.17

u/ml

0.52

134

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

156

1.15

0.18

1.1

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.17

0.17

15.4

12.2

0.60

0.23

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

301

1.10

0.17

3.9

7.0

8.80

221.36

ug/l

1.19

194

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.18

0.16

1.0

—

(3014271) Vancomycin [Susceptibility]

418

1.08

0.16

2.9

3.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.10

0.15

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

172

0.87

0.15

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.79

0.15

2.5

2.4

0.78

0.63

ug/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

349

0.92

0.15

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

293

1.09

0.15

1.1

—

(4211845) Urine protein measurement

322

1.09

0.15

4.7

3.6

—

(3028717) Thiamine [Mass/volume] in Blood

1.10

0.15

1.3

1.2

59.11

63.78

ug/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

134

1384

0.97

0.12

5.9

3.8

29.03

30.08

mg/l

0.13

101

986

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.18

0.12

1.0

1.1

—

(4024509) Urine culture

306

3121

0.98

0.12

2.2

2.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

181

1.11

0.12

1.0

1.1

0.75

1.57

u/ml

0.68

(4146454) Self-monitoring of blood glucose

809

1.04

0.10

2.5

2.7

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.14

0.10

1.2

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

134

0.90

0.08

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

390

1.05

0.08

2.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

381

1.05

0.08

2.1

1.7

93.17

90.93

umol/l

0.11

381

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

538

5328

1.01

0.07

1.5

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.84

0.07

1.0

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

207

1.06

0.06

23.0

19.3

1430.50

1383.09

nmol/l

0.12

200

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

422

0.97

0.03

1.9

1.4

0.18

0.27

nmol/l

1.33

305

(4281824) Cell count and differential, peritoneal fluid

583

0.98

0.03

1.1

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

234

2323

1.01

0.03

3.3

4.0

59.44

82.28

u/ml

0.79

226

2228

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

221

1.04

0.03

1.3

1.9

1716.20

17082.77

e6/l

—

124

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

4363

43599

1.00

0.02

45.1

25.4

329.31

331.62

g/l

51.64

4343

43311

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

124

1228

1.01

0.02

2.1

1.9

193.07

201.72

pmol/l

0.50

112

1146

(4094501) Cardiovascular stress test using bicycle ergometer

161

1622

0.99

0.02

1.1

—

(3006270) Folate [Moles/volume] in Blood

539

0.98

0.02

1.1

1.2

311.02

337.04

nmol/l

0.39

425

(3036071) Salmonella sp Ab [Titer] in Serum

144

1.04

0.00

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

146

0.96

0.00

2.1

2.3

7.63

7.99

mmol/l

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

166

0.96

0.00

1.0

1.1

0.60

3.13

u/ml

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

113

0.97

0.00

2.4

1.7

0.33

1.77

u/ml

—

(4133840) Spirometry

126

1.03

0.00

1.3

1.2

—

(3002619) Bacteria identified in Specimen by Culture

144

0.97

0.00

1.3

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

196

1.02

0.00

17.8

14.5

831.85

815.57

nmol/l

0.05

186

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

251

1.00

0.00

1.4

1.3

6.05

6.13

mmol/l

0.13

236

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.8

—

0.27

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.98

0.00

2.2

2.0

14.33

18.63

umol/l

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

25.80

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

5.8

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

40.00

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

5.8

—

14.00

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.95

-0.00

1.2

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.01

-0.00

1.0

1.1

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

590

1.00

-0.00

2.5

3.1

56.65

48.87

mg/l

0.12

443

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

-0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

1.80

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3444.14

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ILD_HOSPITAL – ILD, hospital admissions

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

ILD, hospital admissions

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for ILD, hospital admissions (ILD_HOSPITAL)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints